[{"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0708-2021", "product_description": "HYDROMORPHONE HCL-BUPIVACAINE HCL-BACLOFEN PF INJECTABLE 21 mL syringes in  various strengths:  a)  2.5MG-1.25MG-0.5MCG/ML, b) 10MG-5MG-10MCG/ML, c) 2MG-1MG-10MCG/ML, d) 10MG-5MG-10MCG/ML, e) 15MG-5MG-2000MCG/ML, f) 8MG-10MG-400MCG/ML, Rx only,  Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "126 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: a)10012020@42, b) 10012020@43, c) 10012020@44, d) 10012020@46, e) 09302020@16, f) 09302020@44, BUD 10/29/2020"}, {"status": "Terminated", "city": "San Nicolas De Los Georgia", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86078", "recalling_firm": "Liq-E S.A. De C.V.", "address_1": "Puerto Tampico 345", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the United States and Mexico.", "recall_number": "D-0253-2021", "product_description": "OPTIMUS LUBRICANTS  Instant Hand Sanitizer, (ethyl alcohol 70%) 8.5 Fl. Oz. (250 mL) bottle, Made in Mexico, Liq-E, S.A. DE C.V., Puerto Tampico No. 345 Col. La Fe San Nicolas de Los Garza, Nuevo Leon, Mexico. C.P. 66477. UPC # 7 501799 115621", "product_quantity": "12,201 bottles", "reason_for_recall": "Chemical Contamination: Products contain methanol and were below the label claim for ethanol content", "recall_initiation_date": "20200720", "center_classification_date": "20210212", "termination_date": "20240408", "report_date": "20210224", "code_info": "Lot # (L)20-02, exp. date 05/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0516-2021", "product_description": "VITAMIN D3 25MCG 180 TABLETS; NDC/UPC 880681168011; OTC; TABLETS", "product_quantity": "19 BOTTLE", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0275-2021", "product_description": "MethyIPREDNISolone Acetate Injectable Suspension USP,   40 mg/mL, 1 mL Single-Dose Vial (NDC 0703-0031-01), packaged in 25X1ML per tray (NDC 0703-0031-04), Rx only, TEVA PHARMACEUTICALS USA, INC., North Wales, PA  19454.", "product_quantity": "5,086 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327742B, exp. date 02/2021  Lot # 31328408B, exp. date 07/2021"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0209-2021", "product_description": "Morphine Sulfate 30 mg/30 mL in 0.9% Sodium Chloride (1mg/ml), CII, Rx Only, 30 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004010016", "product_quantity": "116 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220023412, BUD 2/2/2021; 12220023500, BUD 2/3/2021 & 1220023689 BUD 2/11/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA021359"], "brand_name": ["RECTIV"], "generic_name": ["NITROGLYCERIN"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["58914-301"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RECTAL"], "substance_name": ["NITROGLYCERIN"], "rxcui": ["1114466", "1114470"], "spl_id": ["f971b230-ba2a-4150-9357-dde0658f2bac"], "spl_set_id": ["603aa9ed-54c4-4a35-ade4-690fa44850e4"], "package_ndc": ["58914-301-80", "58914-301-85"], "is_original_packager": [true], "upc": ["0358914301806"], "nui": ["N0000175415", "M0014874", "N0000009909"], "pharm_class_epc": ["Nitrate Vasodilator [EPC]"], "pharm_class_cs": ["Nitrates [CS]"], "pharm_class_pe": ["Vasodilation [PE]"], "unii": ["G59M7S0WS3"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0419-2021", "product_description": "Rectiv (nitroglycerin) Ointment 0.4% For Intra-anal Use Only 30 g Rx Only NDC 58914-301-80 Mfd. by: Pharbil Waltrop GmbH, Im Wirrigen 25, 45731 Waltrop, Germany Distributed by: Aptalis Pharma US, Inc. Birmingham, AL 35242", "product_quantity": "31 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "2399070"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0107-2022", "product_description": "BI-MIX PAPAVERINE 40/PHENTOLAMINE 2 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08182021:00 BUD: 12/16/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Windsor", "state": "CO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88910", "recalling_firm": "TOLMAR, Inc.", "address_1": "1201 Cornerstone Dr", "address_2": "", "postal_code": "80550-5547", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0282-2022", "product_description": "Clindamycin and Benzoyl Peroxide Gel, 1%/5% 25 g jars, Rx only, Mfg by TOLMAR Inc. Fort collins, CO 80526, NDC 0781-7263-68", "product_quantity": "", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20211108", "center_classification_date": "20211214", "termination_date": "20220907", "report_date": "20211222", "code_info": "Lot #: 11557C1, Exp. Date: Feb 2022; 11552B1, Exp. Date Apr 2022; 12206A1, Exp. Date: Nov 2022", "more_code_info": ""}, {"status": "Terminated", "city": "Morelia", "state": "N/A", "country": "Mexico", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87917", "recalling_firm": "DIBAR NUTRICIONAL S DE RL DE CV", "address_1": "Sargento Manuel De La Rosa #145", "address_2": "Col Chapultepec Sur", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0646-2021", "product_description": "ProtectoRx (ethyl alcohol 70%), packaged in a) 2 FL OZ (59 mL), NDC 75408-002-01 and b) 16 FL OZ (473.2 mL), NDC 75408-002-02 bottles, Imported by: Dibar Labs, LLC., Sugar Land, TX  77479; Distributed by: PR Trading LLC, PO Box 19647, San Juan, PR  00910, Made in Mexico.", "product_quantity": "Unknown quantity", "reason_for_recall": "CGMP Deviations: Other lots and products of hand sanitizer recalled because they were manufactured under the same conditions as the product lots found to contain methanol.", "recall_initiation_date": "20210511", "center_classification_date": "20210629", "termination_date": "20230308", "report_date": "20210707", "code_info": "All lots."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0498-2021", "product_description": "INVEGA SUSTENNA 156MG/1ML; NDC/UPC 50458056301; RX; SYRINGES", "product_quantity": "534 syringes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "KIB0M00"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201791"], "brand_name": ["LAMOTRIGINE EXTENDED RELEASE"], "generic_name": ["LAMOTRIGINE EXTENDED RELEASE"], "manufacturer_name": ["Endo USA, Inc."], "product_ndc": ["49884-561", "49884-562", "49884-563", "49884-564", "49884-604", "49884-605"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["LAMOTRIGINE"], "rxcui": ["850087", "850091", "900156", "900164", "1098608", "1146690"], "spl_id": ["1b224518-6e15-47d1-b1ee-b1e1d92f70ae"], "spl_set_id": ["fb59c76a-9b6f-40ea-ac3a-58c3195c4377"], "package_ndc": ["49884-561-11", "49884-561-01", "49884-561-05", "49884-562-11", "49884-562-01", "49884-562-05", "49884-563-11", "49884-563-01", "49884-563-05", "49884-564-11", "49884-564-01", "49884-564-05", "49884-604-11", "49884-604-01", "49884-604-05", "49884-605-11", "49884-605-01", "49884-605-05"], "is_original_packager": [true], "nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "unii": ["U3H27498KS"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0538-2021", "product_description": "Lamotrigine Extended-Release Tablets 250 mg 30 Tablets Rx Only NDC 49884-604-11 Manufactured by: Zhejiang Huahai Pharmaceutical Co., Ltd. Zhejiang 317024 China For Par Pharmaceutical Companes, Inc. Spring Valley, NY 10977 U.S.A.", "product_quantity": "131 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "10116"}, {"country": "United States", "city": "Glendale", "address_1": "610 S Verdugo Rd Apt 31", "reason_for_recall": "Marketed without an approved NDA/ANDA: FDA analysis determined presence of the pharmaceutical ingredients Sibutramine and Fluoxetine", "address_2": "", "product_quantity": "25 pieces (boxes containing 15 sachets)", "code_info": "All Lots", "center_classification_date": "20210611", "distribution_pattern": "Nationwide within the United States", "state": "CA", "product_description": "Imperia Elita Vitaccino Coffee, 10 g sachets, 15 sachets per box, Global Beauty Technologies, Manufactured for: Imperia-Elita Ltd. & Co, KG D- 35435 Wettenberg", "report_date": "20210623", "classification": "Class II", "openfda": {}, "recalling_firm": "DASH XCLUSIVE", "recall_number": "D-0628-2021", "initial_firm_notification": "Press Release", "product_type": "Drugs", "event_id": "87923", "more_code_info": "", "recall_initiation_date": "20210511", "postal_code": "91205-2730", "voluntary_mandated": "Voluntary: Firm initiated", "status": "Ongoing"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0197-2021", "product_description": "Ketamine 100 mg/10mL in 0.9% Sodium Chloride Injection (10 mg/mL), CII, Rx Only, 10 mL Single Dose Syringe, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004043012", "product_quantity": "11,075 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "a) Lot # 1220023076, BUD 1/24/2021 &  1220023549, BUD 2/9/2021.  b) Lot # 1220023040, BUD 1/19/2021; 1220023070, BUD 1/21/2021; 1220023105, BUD 1/25/2021; 1220023158, BUD 1/26/2021; 1220023315, BUD 2/1/2021; 1220023342, BUD 2/2/2021; 1220023431, BUD 2/4/2021;  1220023471, BUD 2/3/2021; 1220023481, BUD 2/4/2021 & 1220023509, BUD 2/8/2021.", "more_code_info": ""}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0848-2021", "product_description": "Neutrogena Beach Defense water+sun protection sunscreen spray BROAD SPECTRUM SPF 70, Avobenzone (3%), Homosalate (15%), Octisalate (5%), Octocrylene (10%), NET WT. 8.5 OZ. (240 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858 UPC 0 86800 10048 5", "product_quantity": "411,180 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0606-2021", "product_description": "DELFELX Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium, Low Calcium, 5000 mL, Fresenius Medical Care, Waltham, MA 02451, NDC  49230-0212-50", "product_quantity": "49 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: 21AK01022, Exp. date July 2022; 20SK01022, Exp. date June 2022"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0042-2022", "product_description": "TEST CYP 100MG/ML IN ETHYL OLEATE OIL, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0860-2021", "product_description": "Yeast Guard Blend,  Calcarea Carbonica 6X, Collinsonia Canadensis 3X, Kali Muriaicum 3X, WHP Homeopathic Medicine, For Manufacturing Use Only. 1.957 kg Lactose, Manufactured by Wasington Homeopathic Products 260 JR Hawvermale Way, Berkeley Springs WV 25411.", "product_quantity": "1.957 kg.", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29782"}, {"status": "Terminated", "city": "Kansas City", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88552", "recalling_firm": "Charles Paint Research Inc", "address_1": "2401 E 85th St", "address_2": "N/A", "postal_code": "64132-2617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in Michigan", "recall_number": "D-0791-2021", "product_description": "HAND SANITIZER (alcohol 80%), Alchol Antiseptic 80% topical solution, Hand Sanitizer non-sterile solution, Net weight (6 lbs 14.2 oz) 1 gallon; Net Quantity (3785 mL), Manufactured by Soapdaddy LLC, 2401 E. 85th Street, Kansas City, MO 64131", "product_quantity": "3,900 gallons", "reason_for_recall": "CGMP Deviations: Product manufactured in same facility where product was found to contain acetaldehyde and acetal above the allowable limits.", "recall_initiation_date": "20200902", "center_classification_date": "20210908", "termination_date": "20230929", "report_date": "20210915", "code_info": "Lot# 20-151 to 20-159 and 20-161 to20-163, Exp 06/11/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0067-2022", "product_description": "SODIUM SELINITE 200MCG/ML FOR INJ, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0706-2021", "product_description": "FENTANYL-BUPIVACAINE HCL PF INJECTABLE 3000MCG-12MG/ML, 21 mL syringe, Rx only,  Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "21 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: 09302020@67 BUD: 10/29/2020"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88382", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "N/A", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0785-2021", "product_description": "Lidocaine Ointment USP, 5% Rx Only, Net Wt 35.44 g(1 1/4 oz)packaged in a laminat tube, Teligent Pharma, Inc. Buena, New Jersey 08310, NDC 52565-008-14.", "product_quantity": "114,456 tubes", "reason_for_recall": "Failed Viscosity Specifications: lot does not meet specification for Viscosity, which was determined through routine testing.", "recall_initiation_date": "20210729", "center_classification_date": "20210831", "termination_date": "20240815", "report_date": "20210908", "code_info": "Lot #: 15378, Exp 3/2023; 14418 EXP 10/2021"}, {"status": "Completed", "city": "Birmingham", "state": "AL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA075388"], "brand_name": ["BUSPIRONE HYDROCHLORIDE"], "generic_name": ["BUSPIRONE HYDROCHLORIDE"], "manufacturer_name": ["Oxford Pharmaceuticals, LLC"], "product_ndc": ["69584-091", "69584-092", "69584-093", "69584-094"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["BUSPIRONE HYDROCHLORIDE"], "rxcui": ["866018", "866083", "866090", "866094"], "spl_id": ["8c9f66ca-78a9-418c-b11e-ba4391843257"], "spl_set_id": ["97fcebc1-6615-4b9d-b0f3-6434850f407c"], "package_ndc": ["69584-091-10", "69584-091-50", "69584-092-10", "69584-092-50", "69584-093-06", "69584-093-10", "69584-093-50", "69584-094-06", "69584-094-18", "69584-094-50"], "is_original_packager": [true], "upc": ["0369584093502"], "unii": ["207LT9J9OC"]}, "product_type": "Drugs", "event_id": "87873", "recalling_firm": "Oxford Pharmaceuticals, LLC", "address_1": "301 Leaf Lake Pkwy", "address_2": "", "postal_code": "35211-7208", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide.", "recall_number": "D-0602-2021", "product_description": "BusPIRone Hydrochloride Tablets, USP, 15 mg, 100-count bottle, Rx only, Manufactured By: Oxford Pharmaceuticals, LLC Birmingham, Alabama 35211, NDC 69584-093-10", "product_quantity": "6,864 bottles", "reason_for_recall": "Presence of Foreign Tablets/Capsules", "recall_initiation_date": "20210505", "center_classification_date": "20210602", "report_date": "20210609", "code_info": "Lot #: C21021A, Exp. 03/2023", "more_code_info": ""}, {"status": "Terminated", "city": "East Brunswick", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA090687"], "brand_name": ["TACROLIMUS"], "generic_name": ["TACROLIMUS"], "manufacturer_name": ["Strides Pharma Science Limited"], "product_ndc": ["64380-720", "64380-721", "64380-722"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["TACROLIMUS"], "rxcui": ["198377", "198378", "313190"], "spl_id": ["48cd3633-d3c0-4197-aa6b-033887913404"], "spl_set_id": ["ed7d1495-3585-409d-94f1-b3d2469d222c"], "package_ndc": ["64380-720-06", "64380-720-01", "64380-721-06", "64380-721-01", "64380-722-01", "64380-722-06"], "is_original_packager": [true], "upc": ["0364380721062", "0364380720065", "0364380722069"], "unii": ["WM0HAQ4WNM"]}, "product_type": "Drugs", "event_id": "87027", "recalling_firm": "Strides Pharma Inc.", "address_1": "2 Tower Center Blvd Ste 1102", "address_2": "N/A", "postal_code": "08816-1100", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "PA", "recall_number": "D-0180-2021", "product_description": "NDC 64380-721-06 TACROLIMUS CAPSULES, USP 1mg 100 Capsules Rx Only Manufactured by: Strides Pharma Science Ltd. Bengaluru - 562106, India Distributed by: Strides Pharma Inc. East Brunswick, NJ 08816", "product_quantity": "960 bottles", "reason_for_recall": "Failed Moisture Limits", "recall_initiation_date": "20201222", "center_classification_date": "20201230", "termination_date": "20220126", "report_date": "20210106", "code_info": "Lot 7242728A; June 2023"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0156-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 0.75MG/DUTASTERIDE 1MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot:  T1008312021:33 BUD: 02/27/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Brookhaven", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA201764"], "brand_name": ["FLUOCINOLONE ACETONIDE"], "generic_name": ["FLUOCINOLONE ACETONIDE"], "manufacturer_name": ["Amneal Pharmaceuticals LLC"], "product_ndc": ["65162-704"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["FLUOCINOLONE ACETONIDE"], "rxcui": ["1191307"], "spl_id": ["996705c7-5da7-4539-8bf3-36efe8e9f51a"], "spl_set_id": ["64586ff9-941a-418a-a870-ffb5dafbe24b"], "package_ndc": ["65162-704-86"], "is_original_packager": [true], "nui": ["N0000175576", "N0000175450"], "pharm_class_epc": ["Corticosteroid [EPC]"], "pharm_class_moa": ["Corticosteroid Hormone Receptor Agonists [MoA]"], "unii": ["0CD5FD6S2M"]}, "product_type": "Drugs", "event_id": "88997", "recalling_firm": "Amneal Pharmaceuticals of New York, LLC", "address_1": "50 Horseblock Rd", "address_2": "N/A", "postal_code": "11719-9509", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide within the United States", "recall_number": "D-0233-2022", "product_description": "Flocinolone Acetonide 0.01% Topical Oil, Body Oil, Rx, packaged in 4 oz. bottle, Distributed by: Amneal Pharmaceuticals Bridgewater, NJ 08807, NDC 65162-704-86", "product_quantity": "7,766 bottles", "reason_for_recall": "Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.", "recall_initiation_date": "20211104", "center_classification_date": "20211116", "termination_date": "20220609", "report_date": "20211124", "code_info": "Lot #: 07040001A, exp. date 02/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Wilton", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88770", "recalling_firm": "Beiersdorf Inc", "address_1": "45 Danbury Rd", "address_2": "N/A", "postal_code": "06897-4405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0016-2022", "product_description": "Coppertone Pure & Simple kids 50 Sunscreen Spray (To Deliver) Zinc Oxide 24.08%, NET WT 5 OZ (142 g) can, Beiersdorf Inc., Wilton, CT 06897  UPC 0 72140 02882 4", "product_quantity": "70,320 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210930", "center_classification_date": "20211015", "termination_date": "20230413", "report_date": "20211027", "code_info": "Lot# TN00857, exp. date 04/30/2023"}, {"status": "Terminated", "city": "Fairview", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87324", "recalling_firm": "Adams.Secret.co", "address_1": "29-31 Industrial Ave", "address_2": "N/A", "postal_code": "07022-1625", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0311-2021", "product_description": "Adam's Secret Extra Strength 3000, 840 mg, 10 count blister packs, Distributed by AS Inc.,  Made in USA, UPC 6 09728 43452 6.", "product_quantity": "N/A", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of  tadalafil and sildenafil.", "recall_initiation_date": "20210215", "center_classification_date": "20210319", "termination_date": "20220420", "report_date": "20210331", "code_info": "All lots within expiry.", "more_code_info": ""}, {"status": "Terminated", "city": "Lynnwood", "state": "WA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["BLA103362"], "brand_name": ["LEUKINE"], "generic_name": ["SARGRAMOSTIM"], "manufacturer_name": ["Partner Therapeutics, Inc."], "product_ndc": ["71837-5843"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAVENOUS", "SUBCUTANEOUS"], "substance_name": ["SARGRAMOSTIM"], "rxcui": ["208083", "315199"], "spl_id": ["4ad3993c-6c7f-4a33-8ead-a912636ff4a1"], "spl_set_id": ["bb9a3820-f31a-4dd9-bef4-97094c01a398"], "package_ndc": ["71837-5843-1", "71837-5843-5"], "is_original_packager": [true], "upc": ["0371837584354"], "nui": ["M0024696", "M0024695", "N0000009451", "N0000175666"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]", "Granulocyte-Macrophage Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "unii": ["5TAA004E22"]}, "product_type": "Drugs", "event_id": "88164", "recalling_firm": "Partner Therapeutics Inc", "address_1": "2625 162nd St Sw", "address_2": "", "postal_code": "98087-3263", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Product was distributed to one government account (ASPR)", "recall_number": "D-0655-2021", "product_description": "LEUKINE (Sargramostim) for Injection, 250 mcg/ vial, 5mL vials, 5 (250 mcg vials) per box, Rx only, Mfd by Partner Therapeutics, Inc. Lexington, MA 02421, NDC 71837-5843-5", "product_quantity": "32,260 vials", "reason_for_recall": "FAILED STABILITY SPECIFICATION: Out-of-specification (OOS) result observed for Leukine (sargramostim) at the 27-month stability timepoint.", "recall_initiation_date": "20210623", "center_classification_date": "20210713", "termination_date": "20230207", "report_date": "20210721", "code_info": "Lot #: E8023E, exp. date 11/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88738", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0024-2022", "product_description": "AirDuo Digihaler 113/14 (fluticasone propionate 113 mcg and salmeterol 14 mcg) Inhalation Powder, Rx Only, Mktd. by: Teva Respiratory, LLC, Frazer, PA 19355, Manufactured in Ireland, NDC 59310-129-06.", "product_quantity": "4,850 inhalers", "reason_for_recall": "Subpotent drug: OOS results of Label Claimed Emitted Dose for salmeterol", "recall_initiation_date": "20210922", "center_classification_date": "20211021", "termination_date": "20230216", "report_date": "20211027", "code_info": "AFR17A"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0875-2021", "product_description": "Althaea 30X, Iritable Bladder* Sucrose/Lactose Pills,  packaged as 4 Dram,  WHP Homeopathic Medicine, Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.", "product_quantity": "10 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29377, Exp 8/17/2026"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA208751"], "brand_name": ["FIASP"], "generic_name": ["INSULIN ASPART INJECTION"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-3201", "0169-3204", "0169-3205", "0169-3206"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN ASPART"], "rxcui": ["311040", "1653196", "1653202", "1986354", "1986356", "2205454", "2642808", "2642809"], "spl_id": ["133d5f6e-b40f-47b6-ab47-10dc37114d79"], "spl_set_id": ["834e7efc-393f-4c55-9125-628562a8a5cf"], "package_ndc": ["0169-3201-11", "0169-3201-90", "0169-3204-15", "0169-3204-90", "0169-3204-97", "0169-3205-11", "0169-3205-15", "0169-3205-91", "0169-3205-95", "0169-3206-11", "0169-3206-15", "0169-3206-91", "0169-3206-95"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["D933668QVX"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0612-2021", "product_description": "Fiasp PenFill (insulin aspart injection) 100 units/mL (U-100), 3 mL cartridge, 5 cartridges per package, Sample Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark,  NDC 0169-3205-91", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KS6BF84, Exp 06/30/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA022417"], "brand_name": ["NORVIR"], "generic_name": ["RITONAVIR"], "manufacturer_name": ["AbbVie Inc."], "product_ndc": ["0074-2340", "0074-3333", "0074-1940", "0074-3399"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["RITONAVIR"], "rxcui": ["152971", "199249", "900575", "900577", "1926066", "1926069"], "spl_id": ["8ac33865-3c6e-4159-9eaf-5f62bee5b6ca"], "spl_set_id": ["2849298e-de6e-47bb-8194-56e075b33fc3"], "package_ndc": ["0074-3333-30", "0074-1940-63", "0074-3399-30", "0074-2340-30"], "is_original_packager": [true], "upc": ["0300742340304"], "nui": ["N0000000246", "N0000191001", "N0000175889", "N0000190114", "N0000182137", "N0000185607", "N0000190118", "N0000185503", "N0000190113", "N0000182141", "N0000191266", "N0000185507", "N0000187064", "N0000190117"], "pharm_class_moa": ["HIV Protease Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 2C19 Inducers [MoA]", "Cytochrome P450 3A Inducers [MoA]", "P-Glycoprotein Inhibitors [MoA]", "Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 1A2 Inducers [MoA]", "Cytochrome P450 2C9 Inducers [MoA]", "Cytochrome P450 2B6 Inducers [MoA]", "UDP Glucuronosyltransferases Inducers [MoA]"], "pharm_class_epc": ["Cytochrome P450 3A Inhibitor [EPC]", "Protease Inhibitor [EPC]"], "unii": ["O3J8G9O825"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0404-2021", "product_description": "Norvir Ritonavir Tablets 100 mg 30 Tablets Rx only NDC 0074-3333-30 Abbott Laboratories North Chicago, IL 60064, U.S.A.", "product_quantity": "362 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "1131141"}, {"status": "Terminated", "city": "Manassas", "state": "VA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87627", "recalling_firm": "Antoto-K", "address_1": "7686 Chadds Landing Way", "address_2": "N/A", "postal_code": "20111-1772", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0366-2021", "product_description": "Thumbs Up 7 Red 70K, 10 count blister pack cartons, Distributed by Ummzy LLC., Made in USA, UPC 6 17135 89467 3.", "product_quantity": "200 cartons", "reason_for_recall": "Marketed without Approved NDA/ANDA: FDA analysis results obtained the presence of sildenafil and tadalafil.", "recall_initiation_date": "20210326", "center_classification_date": "20210504", "termination_date": "20220418", "report_date": "20210512", "code_info": "All lots within expiry."}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0555-2021", "product_description": "Chantix (varenicline) Tablets Continuing Month Box Contains: 4 Continuing Weeks (1 mg x 56 tablets) Rx only ; Rx only  Distributed by Pfizer Labs Division of Pfizer, Inc., NY, NY ,10017NDC 0069-0469-56", "product_quantity": "848 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "EM1069"}, {"status": "Terminated", "city": "Hauppauge", "state": "NY", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88244", "recalling_firm": "LNK International, Inc.", "address_1": "55 Arkay Dr", "address_2": "N/A", "postal_code": "11788-3707", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed in PA", "recall_number": "D-0665-2021", "product_description": "Acetaminophen EXTRA STRENGTH Pain Reliever / Fever Reducer, Enteric Coated, 50 Coated Tablets/ 500 mg each, Distributed by Amerisource Bergen, 1300 Morris Drive, Chesterbrook, PA, 19087, NDC 46122-649-71", "product_quantity": "8,472 bottles", "reason_for_recall": "Labeling: Not Elsewhere Classified The primary label contains the words \"enteric coated\" but the tablet is not enteric coated and should only say 'coated tablet'", "recall_initiation_date": "20210707", "center_classification_date": "20210716", "termination_date": "20230504", "report_date": "20210728", "code_info": "Lot # P120999, Exp 07/31/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Burbank", "state": "CA", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87283", "recalling_firm": "Bryant Ranch Prepack, Inc. dba BRP Pharmaceuticals", "address_1": "1919 N Victory Pl", "address_2": "N/A", "postal_code": "91504-3425", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0304-2021", "product_description": "Spironolactone Tablets, USP, 50 mg, packaged in 30-count bottles, Rx only, Manufactured by: Frontida BioPharm, Inc., Philadelphia, PA 19124 USA, Repackaged by: Bryant Ranch Prepack, Inc., Burbank, CA 91504 USA, NDC 63629-1067-01", "product_quantity": "12 bottles", "reason_for_recall": "Labeling: Label Mix-Up - Prepackaged bottles labeled spironolactone 50 mg may contain spironolactone 25 mg tablets.", "recall_initiation_date": "20210127", "center_classification_date": "20210316", "report_date": "20210324", "code_info": "Lot #: 148992, Exp 5/31/2022"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA210913"], "brand_name": ["CEQUA"], "generic_name": ["CYCLOSPORINE"], "manufacturer_name": ["Sun Pharmaceutical Industries, Inc."], "product_ndc": ["47335-506", "47335-507"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["OPHTHALMIC", "TOPICAL"], "substance_name": ["CYCLOSPORINE"], "rxcui": ["2055021", "2055026"], "spl_id": ["9db609da-42a0-42b1-87f5-020261a871ad"], "spl_set_id": ["48c3d8a3-4289-4b52-9189-58b48596095c"], "package_ndc": ["47335-506-96", "47335-507-97"], "is_original_packager": [true], "nui": ["N0000175457", "N0000175458", "N0000182141", "N0000185503"], "pharm_class_epc": ["Calcineurin Inhibitor Immunosuppressant [EPC]"], "pharm_class_moa": ["Calcineurin Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "unii": ["83HN0GTJ6D"]}, "product_type": "Drugs", "event_id": "87349", "recalling_firm": "SUN PHARMACEUTICAL INDUSTRIES INC", "address_1": "2 Independence Way", "address_2": "", "postal_code": "08540-6620", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide and Australia", "recall_number": "D-0289-2021", "product_description": "Cequa (cyclosporine ophthalmic solution) 0.09%, 60 Single-Use Vials (6 pouches x 10 single-use vials (0.25 mL each)), Rx only, Manufactured for Sun Pharma Global FZE by: Laboratoire Unither, Coutances, France  NDC 47335-506-96", "product_quantity": "37,400 cartons/60 vials per carton", "reason_for_recall": "Subpotent", "recall_initiation_date": "20210222", "center_classification_date": "20210226", "termination_date": "20220121", "report_date": "20210310", "code_info": "Lot 10007, exp. date 01/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Chicago", "state": "IL", "country": "United States", "classification": "Class III", "openfda": {}, "product_type": "Drugs", "event_id": "88619", "recalling_firm": "Meitheal Pharmaceuticals Inc", "address_1": "8700 W Bryn Mawr Ave Ste 600", "address_2": "N/A", "postal_code": "60631-3512", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA and India", "recall_number": "D-0801-2021", "product_description": "Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21", "product_quantity": "1,160 ten-pack cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210903", "center_classification_date": "20210915", "termination_date": "20240512", "report_date": "20210922", "code_info": "Lot #: G0010120, Exp. Date December 2021; G0080520, Exp. Date April 2022; G0090221, G0100221, Exp. Date January 2023", "more_code_info": ""}, {"status": "Terminated", "city": "Charlotte", "state": "NC", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87255", "recalling_firm": "Stanley Specialty Pharmacy Compounding and Wellness Center", "address_1": "3120 Latrobe Dr Ste 200", "address_2": "N/A", "postal_code": "28211-2185", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0252-2021", "product_description": "Lidocaine/Tetracaine (LIPO110)* 23%/7% Ointment 100 GMS per 4 ounce plastic ointment jar, Rx Only, Stanley Specialty Pharmacy 3120 Latrobe Dr. Suite 200 Charlotte, NC 28211", "product_quantity": "4400 grams (44 jars)", "reason_for_recall": "Superpotent Drug. Lidocaine   higher concentration than listed", "recall_initiation_date": "20210121", "center_classification_date": "20210210", "termination_date": "20220208", "report_date": "20210217", "code_info": "Lot: 195789 Exp. Apr. 17 2021"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0193-2021", "product_description": "fentaNYL 1500 mcg/30 mL (50 mcg/mL), 30 mL Single Dose Syringe, Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095, barcode 70004020016", "product_quantity": "2,834 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "Lot # 1220022977, BUD 1/20/2021;  1220023122, BUD 1/25/2021; 1220023209, BUD 1/28/2021; 1220023248, BUD 1/27/2021; 1220023319, BUD 2/1/2021;  1220023496, BUD 2/8/2021 & 1220023560, BUD 2/9/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "San Nicolas De Los Georgia", "state": "N/A", "country": "Mexico", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "86078", "recalling_firm": "Liq-E S.A. De C.V.", "address_1": "Puerto Tampico 345", "address_2": "N/A", "postal_code": "N/A", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Distributed Nationwide in the United States and Mexico.", "recall_number": "D-0254-2021", "product_description": "OPTIMUS LUBRICANTS Instant Hand Sanitizer, (alcohol 70% v/v) 55 Gal (208 L) drum, Made in Mexico, Liq-E, S.A. DE C.V., Puerto Tampico No. 345 Col.. La Fe San Nicolas de Los Garza, Nuevo Leon, Mexico. C.P. 66477.UPC # 7 501799 118998", "product_quantity": "575 drums", "reason_for_recall": "Chemical Contamination: Products contain methanol and were below the label claim for ethanol content", "recall_initiation_date": "20200720", "center_classification_date": "20210212", "termination_date": "20240408", "report_date": "20210224", "code_info": "Lot #  L-1160, L-2160, L-3160, L-1180, L-2180, L-2190, Exp. 05/2022; L-1200, L-2200, L-3200, L-4200, L-5200, L-1210 and L-2210, Exp. date 06/2022"}, {"status": "Terminated", "city": "Buena", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88884", "recalling_firm": "Teligent Pharma, Inc.", "address_1": "105 Lincoln Avenue", "address_2": "", "postal_code": "08310", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0259-2022", "product_description": "Diclofenac Sodium Topical Solution USP, 1.5 w/w, 5 fl oz (150 mL) plastic bottles, Rx only, Teligent Pharma, Inc., Buena, New Jersey, 08310, NDC 70512-025-05.", "product_quantity": "5400 units", "reason_for_recall": "Defective Container", "recall_initiation_date": "20211019", "center_classification_date": "20211123", "termination_date": "20240618", "report_date": "20211201", "code_info": "Lot #: 15028, Exp 1/2023; 15379, Exp 3/2023.", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0172-2022", "product_description": "TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.5MG/ML INJ #2 IN SESAME OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "9 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1004132021:95 BUD: 10/10/2021; T1006162021:63 BUD: 12/13/2021; T1004282021:19 BUD: 10/25/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA065261"], "brand_name": ["CEFPROZIL"], "generic_name": ["CEFPROZIL"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-401", "68180-402"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["CEFPROZIL"], "rxcui": ["309080", "309081"], "spl_id": ["45d1a412-407b-48d4-be64-b9c7ec3c5205"], "spl_set_id": ["3ec55c0a-1456-412e-972f-352b3135c8f2"], "package_ndc": ["68180-401-03", "68180-401-01", "68180-401-02", "68180-402-01", "68180-402-03", "68180-402-02"], "is_original_packager": [true], "upc": ["0368180401032", "0368180402039"], "nui": ["N0000175488", "M0003827"], "pharm_class_epc": ["Cephalosporin Antibacterial [EPC]"], "pharm_class_cs": ["Cephalosporins [CS]"], "unii": ["4W0459ZA4V"]}, "product_type": "Drugs", "event_id": "87602", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Puerto Rico", "recall_number": "D-0332-2021", "product_description": "Cefprozil for Oral Suspension USP, 250mg/5mL, packaged as a) 50 mL (when mixed) bottles (NDC 68180-402-01); b) 75 mL (when mixed) bottles (NDC 68180-402-02); and c) 100 mL (when mixed) bottles (NDC 68180-402-03); Rx only, Manufactured for: Lupin Pharmaceutical, Inc., Baltimore, MD  21202; Manufactured by: Lupin Limited, Mandideep 462 046, India.", "product_quantity": "a) 6,816 bottles; b) 3,960 bottles and c) 7,038 bottles", "reason_for_recall": "Superpotent Drug", "recall_initiation_date": "20210326", "center_classification_date": "20210412", "termination_date": "20211216", "report_date": "20210421", "code_info": "Lot Numbers: a) F801122, exp. date June 2021; b) F801123, exp. date June 2021; c) F801124, exp. date June 2021"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0048-2022", "product_description": "TEST CYP/PROP/DECA-NAN 125MG/ML (80/10/10) IN SESAME OIL, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Clatskanie", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88222", "recalling_firm": "Cascade Kelly Holdings LLC", "address_1": "81200 Kallunki Rd", "address_2": "", "postal_code": "97016-2244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to the firm's affiliated facilities and donated third party recipients located in the following states: CT, MA, ME, ND, NY, OR, PA, TX, VT.", "recall_number": "D-0698-2021", "product_description": "Global Hand Sanitizer with moisturizer, Alcohol-based Antiseptic 80%, Non-sterile Topical Solution, 8 fl. oz./236 mL, Alcohol 80% v/v, Manufactured by: Cascade Kelly Holdings LLC, NDC 80253-001-02", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Does not meet monograph for denaturant.", "recall_initiation_date": "20210630", "center_classification_date": "20210730", "termination_date": "20220720", "report_date": "20210811", "code_info": "All distributed lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078314"], "brand_name": ["NAPROXEN SODIUM"], "generic_name": ["NAPROXEN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-178", "68462-188", "68462-189", "68462-190", "68462-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NAPROXEN SODIUM"], "rxcui": ["198012", "198013", "198014", "849398", "849431"], "spl_id": ["b7cce793-fe49-4fe0-8848-fc89f7ea3832"], "spl_set_id": ["6c5bb008-e66f-4ef0-bf84-aca7eb5983e9"], "package_ndc": ["68462-188-01", "68462-188-05", "68462-189-01", "68462-189-05", "68462-190-30", "68462-190-50", "68462-190-01", "68462-190-05", "68462-178-01", "68462-178-05", "68462-179-01", "68462-179-05"], "is_original_packager": [true], "upc": ["0368462190012", "0368462179017", "0368462178010", "0368462189016", "0368462188019"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["9TN87S3A3C", "57Y76R9ATQ"]}, "product_type": "Drugs", "event_id": "88591", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0822-2021", "product_description": "Naproxen Sodium Tablets, USP 550 mg Rx Only Manufactured by: Glenmark Pharmaceuticals Inc., USA 4147 Goldmine Road Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430 a) 100 Tablets NDC 68462-179-01; b) 500 Tablets NDC 68462-179-05", "product_quantity": "a) 31248 bottles; b) 300 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210827", "center_classification_date": "20210921", "termination_date": "20231004", "report_date": "20210929", "code_info": "Lots: a) 29190082 Exp. 09/30/2021; 29190083 Exp. 09/30/2021; 29190084 Exp. 10/31/2021; 29190085 Exp. 10/31/2021; 29200001 Exp. 12/31/2021; 29200003 Exp. 01/31/2022; 29200004 Exp. 01/31/2022; 29200005 Exp. 01/31/2022; 29200012 Exp. 02/28/2022; 29200013 Exp. 02/28/2022; b) 29200010 Exp. 02/28/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fb023a-a8db-cd70-e063-6394a90a14f9"], "spl_set_id": ["c29bdfa0-4976-11e2-939b-0002a5d5c51b"], "package_ndc": ["49230-206-92", "49230-206-94", "49230-206-95", "49230-209-92", "49230-209-94", "49230-209-95", "49230-212-92", "49230-212-94", "49230-212-95"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0609-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low magnesium, Low Calcium and attached stay safe Exchange set, 2000 mL, packs of 5, Rx only, Fresenius Medical Care NA, Waltham, MA 02451, NDC 49230-212-92", "product_quantity": "4 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: 20PU04030, Exp. date June 2022"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0124-2022", "product_description": "MEDROXYPROGESTERONE ACET 150MG/ML SUSP (PF)  150MG/ML SUSPENSION, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "696 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 07222021:40 BUD: 10/20/2021; 03302021:60 BUD: 10/26/2021; 04122021:29 BUD: 11/08/2021; 08172021:38 BUD: 11/15/2021; 07072021:60 BUD: 10/05/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA208583"], "brand_name": ["XULTOPHY 100/3.6"], "generic_name": ["INSULIN DEGLUDEC AND LIRAGLUTIDE"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-2911"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN DEGLUDEC", "LIRAGLUTIDE"], "rxcui": ["1860167", "1860172"], "spl_id": ["7ade72ef-d354-430d-afad-3b63b95f5b39"], "spl_set_id": ["21335fe4-d395-4501-ac2a-2f20d7520da9"], "package_ndc": ["0169-2911-15", "0169-2911-90", "0169-2911-97"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453", "N0000178480", "M0160181", "N0000020058"], "pharm_class_cs": ["Insulin [CS]", "Glucagon-Like Peptide 1 [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]", "GLP-1 Receptor Agonist [EPC]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["54Q18076QB", "839I73S42A"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0623-2021", "product_description": "Xultophy 100/3.6 (insulin degludec and liraglutide injection), 100 units/mL and 3.6 mg/mL, 3 mL Prefilled Pen, SAMPLE, Rx only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc, Plainsboro, NJ 08536, NDC 0169-2911-90 (Pen) NDC 0169-2911-97 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "JP54291, exp 06/20/2021"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0462-2021", "product_description": "Sodium Sulfacetamide 9.8% & Sulfur 4.8% Cleanser (sodium sulfacetamide 9.8% and sulfur 4.8%) Net Wt. 10 oz. (285 g) Rx Only NDC 50096-502-10 Manufactured for: Rosemar Labs, LLC 2100 West Loop South Suite 900 Houston, TX 77027", "product_quantity": "16 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "59314"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA021536"], "brand_name": ["LEVEMIR"], "generic_name": ["INSULIN DETEMIR"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-3687", "0169-6438", "0169-6432"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN DETEMIR"], "rxcui": ["484322", "616238", "847239", "847241"], "spl_id": ["580c8514-2277-42bd-9f60-58cf1a6f0b7b"], "spl_set_id": ["d38d65c1-25bf-401d-9c7e-a2c3222da8af"], "package_ndc": ["0169-3687-12", "0169-3687-92", "0169-6438-10", "0169-6438-90", "0169-6438-97", "0169-6438-98", "0169-6432-55", "0169-6432-10"], "is_original_packager": [true], "nui": ["N0000004931", "N0000175453"], "pharm_class_cs": ["Insulin [Chemical/Ingredient]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["4FT78T86XV"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0614-2021", "product_description": "Levemir FlexTouch (insulin detemir) injection, 100 units/mL (U-100), 3 mL Prefilled Pen, Sample, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, Distributed by: Novo Nordisk Inc., Plainsboro, NJ 08536, NDC 0169-6438-90 (Pen), NDC 0169-6438-98 (Kit)", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KP51933 exp 07/31/2022"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0152-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 0.5MG/DUTASTERIDE 0.75MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "2 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot:  T1005192021:31 BUD: 11/15/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA205625"], "brand_name": ["ARNUITY ELLIPTA"], "generic_name": ["FLUTICASONE FUROATE"], "manufacturer_name": ["GlaxoSmithKline LLC"], "product_ndc": ["0173-0874", "0173-0888", "0173-0876"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["RESPIRATORY (INHALATION)"], "substance_name": ["FLUTICASONE FUROATE"], "rxcui": ["1547658", "1547660", "1547663", "1547664", "1547666", "1547668", "1547671", "1547672", "2045377", "2045382"], "spl_id": ["99087493-3503-425e-91e3-ba430d16104f"], "spl_set_id": ["50f193ee-1691-486d-9370-a664df63695c"], "package_ndc": ["0173-0888-10", "0173-0874-10", "0173-0874-14", "0173-0876-10", "0173-0876-14"], "is_original_packager": [true], "unii": ["JS86977WNV"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0480-2021", "product_description": "Arnuity Ellipta (fluticasone furoate inhalation powder) 200 mcg 1 Ellipta Inhaler containing 1 Foil Strip of 30 Blisters Rx Only NDC 0173-0876-10 GlaxoSmithKline Research Triangle Park, NC 27709", "product_quantity": "353 inhalers", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "5U3D"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209178"], "brand_name": ["IBUPROFEN"], "generic_name": ["IBUPROFEN ORAL"], "manufacturer_name": ["Aurobindo Pharma Limited"], "product_ndc": ["59651-032"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["IBUPROFEN"], "rxcui": ["197803"], "spl_id": ["82801fa0-32ef-4b77-b03f-fde7331293ae"], "spl_set_id": ["758eeb45-e599-4c1a-969d-8fa33f27bf14"], "package_ndc": ["59651-032-12", "59651-032-47"], "is_original_packager": [true], "upc": ["0359651032121"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["WK2XYI10QM"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0437-2021", "product_description": "IBUPROFEN ORAL SUSPENSION USP 100MG/5ML 120ML ; NDC/UPC 59651-032-12; RX; SUSPENSION (NO DROPS)", "product_quantity": "345 CARTONS", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "BO1020069-A"}, {"status": "Ongoing", "city": "Miami", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["NDA020870"], "brand_name": ["COMBIPATCH (ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM)"], "generic_name": ["ESTRADIOL/NORETHINDRONE ACETATE TRANSDERMAL SYSTEM"], "manufacturer_name": ["Noven Therapeutics, LLC"], "product_ndc": ["68968-0514", "68968-0525"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TRANSDERMAL"], "substance_name": ["ESTRADIOL", "NORETHINDRONE ACETATE"], "rxcui": ["1251493", "1251495", "1251499", "1251501"], "spl_id": ["a8dddb67-4c56-4d1d-a4ce-83dc426d33f6"], "spl_set_id": ["83198ef1-11c4-11e4-9191-0800200c9a66"], "package_ndc": ["68968-0514-8", "68968-0525-8", "68968-0525-2"], "is_original_packager": [true], "nui": ["M0447348", "N0000175825", "N0000000100"], "pharm_class_cs": ["Estradiol Congeners [CS]"], "pharm_class_epc": ["Estrogen [EPC]"], "pharm_class_moa": ["Estrogen Receptor Agonists [MoA]"], "unii": ["4TI98Z838E", "9S44LIC7OJ"]}, "product_type": "Drugs", "event_id": "88342", "recalling_firm": "Noven Pharmaceuticals Inc", "address_1": "11960 Sw 144th St", "address_2": "N/A", "postal_code": "33186-6109", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0725-2021", "product_description": "Combipatch (estradiol/norethindrone acetate transdermal system) 0.05/0.25 mg per day 50/250 Twice Weekly Rx Only a) 2 Systems NDC 68968-0525-2; b) 8 Systems NDC 68968-0525-8, Mfd. by: Noven Pharmaceuticals, Inc., Miami, Florida 33186, Dist. by: Noven Therapeutics LLC, Miami, Florida 33186", "product_quantity": "70,638 boxes", "reason_for_recall": "Failed Stability Specifications; out of specification for shear.", "recall_initiation_date": "20210730", "center_classification_date": "20210813", "report_date": "20210825", "code_info": "Lots: 88540 Exp. 03/2022; 89118 Exp. 05/2022; 89244 Exp. 07/2022; 89244 (sample lot) Exp. 07/2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0505-2021", "product_description": "SILADRYL 12.5/5ML 118ML SF AF; NDC/UPC 354838135404; OTC; LIQUID", "product_quantity": "78 bottles", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021."}, {"status": "Terminated", "city": "Clatskanie", "state": "OR", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88222", "recalling_firm": "Cascade Kelly Holdings LLC", "address_1": "81200 Kallunki Rd", "address_2": "", "postal_code": "97016-2244", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed to the firm's affiliated facilities and donated third party recipients located in the following states: CT, MA, ME, ND, NY, OR, PA, TX, VT.", "recall_number": "D-0697-2021", "product_description": "Global Hand Sanitizer with moisturizer, Alcohol-based Antiseptic 80%, Non-sterile Topical Solution, 4 fl. oz./119 mL, Alcohol 80% v/v, Manufactured by: Cascade Kelly Holdings LLC, NDC 80253-001-01", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Does not meet monograph for denaturant.", "recall_initiation_date": "20210630", "center_classification_date": "20210730", "termination_date": "20220720", "report_date": "20210811", "code_info": "All distributed lots within expiry", "more_code_info": ""}, {"status": "Terminated", "city": "Sarasota", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87511", "recalling_firm": "Sanit Technologies, LLC dba Durisan", "address_1": "7810 25th Ct E Unit 106", "address_2": "", "postal_code": "34243-2841", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA and Bahamas", "recall_number": "D-0658-2021", "product_description": "Durisan Antimicrobial Solutions (benzalkonium chloride) Hand Sanitizer, listed as 0.1% or 0.13%, Alcohol-Free, packaged in a) 18 mL Net Content 0.61 fl oz credit card size container, (UPC 8 52379 00614 1); b) 50 mL Net Content 1.69 oz bottle, (UPC 8 52379 00634 9 and 8 52379 00612 7); c) 118 mL Net Content 4 oz bottle, (UPC 8 52379 00634 9 and 8 52379 00612 9); d) 236.58 mL Net Content 8 oz bottle, (UPC 8 52379 00635 6); e) 250 mL Net Contents 8.45 oz (UPC 8 52379 00611 0); f) 300 mL Net Content 10 oz bottle, (UPC 8 52379 00697 4); g) 550 mL Net Content 18.59 oz bottle, (UPC 8 52379 00620 2) ; h) 1000 mL Net Content 33.81 oz kidney bottle dispensing 0.4 or 0.8 each actuation, (UPC 8 50008 48507 7 and 8 52379 00610 3); and i) 1 Gallon Net Content 128 oz bottle, (UPC 8 52379 00621 9); Sanit Technologies, LLC 7810 25th Court East, Unit 106 Sarasota, Florida 34243", "product_quantity": "8,609,863 credit card size containers, 665,395 bottles, and 70,462 kidney bottles TOTAL", "reason_for_recall": "CGMP Deviations: lots recalled due to CGMP deviations because they were manufactured under the same conditions as product lots found to be contaminated.", "recall_initiation_date": "20210310", "center_classification_date": "20210713", "termination_date": "20220119", "report_date": "20210721", "code_info": "Lots: DHS041519A1-S, DHS041519A2-S, DHS041519A3-S, DHS041519A4-S, DHS041519A5-S, DHS041519A6-S, Exp. 5/15/2021; DHS042919AR1-S, Exp. 5/29/2021; DHS043019AR1-S, Exp. 5/30/2021;   DHS050319A4-S, Exp. 6/03/2021; DHS053019A1-S, DHS053019A2-S, DHS053019A4-S, DHS053019A5-S, DHS053019A6-S, Exp. 6/30/2021; DHS070219A1-S, DHS070219A2-S, DHS070219A3-S, DHS070219A4-S, DHS070219A5-S, DHS070219A6-S, DHS070219AB-S, Exp. 8/2/2021; DHS080219A1-S, Exp. 9/2/2021; DHS091819A1-S, Exp 10/18/2021; DHS032820B1-S, Exp 4/28/2022; DHS051520A1R1-S, Exp. 6/15/2022; DHS052020A1R1-S, DHS052020B1R1-S, DHS052020CR1-S, Exp. 6/20/2022; DHS052220A1R1-S, Exp. 6/22/2022; DHS052720C1R1-S, Exp 6/27/2022; DHS052920A1R1-S, DHS052920B1R1-S, DHS052920C1R1-S, Exp 6/29/2022; DHS060320C1R1-S, Exp. 7/3/2022; DHS060520C1R1-S, DHS060520F1R1-S, Exp. 7/5/2022; DHS060820E1R1-S, Exp. 7/8/2022; DHS061220A1R1-S, Exp. 7/12/2022; DHS061920B1R1-S, Exp. 7/19/2022; DHS062320B1R1-S, Exp. 7/23/2022; DHS062420B1R1-S, Exp. 7/24/2022; DHS081120A1-S, Exp. 9/11/2022; DHS081220A1R1-S, Exp 9/12/2022; DHS081420B1-S, DHS081420B3-S, DHS081420B6-S, DHS081420B8-S, Exp. 9/14/2022; DHS081720A3-S, DHS081720A5-S, Exp. 9/17/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Miami Lakes", "state": "FL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87076", "recalling_firm": "Complete Pharmacy and Medical Solutions, LLC.", "address_1": "5829 Nw 158th St", "address_2": "N/A", "postal_code": "33014-6721", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0234-2021", "product_description": "HUMAN CHORIONIC GONADOTROPIN 11,000 IU per vial Aso contains Mannitol 9%, Sodium Phosphate 2% in water for injection. Lyophilized, Unpreserved. Complete Pharmacy & Medical Solutions 5829 NW 158th St, Miami Lakes, FL 33014 Tel: 305-397-2035", "product_quantity": "1182 vials", "reason_for_recall": "CGMP deviations: Lack of potency testing.", "recall_initiation_date": "20201120", "center_classification_date": "20210119", "termination_date": "20220928", "report_date": "20210127", "code_info": "Lot #: 40568 Use By Date: 01/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88442", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed Nationwide, including Puerto Rico.", "recall_number": "D-0747-2021", "product_description": "Leucovorin Calcium for Injection, USP 350 mg/vial, 17.5 mL single-use vials, Rx only, Manufactured by: Teva Pharmaceuticals USA, Inc. North Wales, PA 19454, NDC 0703-5145-91", "product_quantity": "42,046 vials", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210729", "center_classification_date": "20210816", "termination_date": "20240604", "report_date": "20210825", "code_info": "Lot #: 313282585B, exp. date 11/2022"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0194-2022", "product_description": "TRI-MIX PAPAVERINE 23.3/PHENTOLAMINE 1/PGE-1 12 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 08102021:71 BUD: 11/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Venice", "state": "FL", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "87828", "recalling_firm": "Scentsational Soaps & Candles Inc", "address_1": "730 Commerce Dr", "address_2": "N/A", "postal_code": "34292-1726", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "USA Nationwide", "recall_number": "D-0670-2021", "product_description": "SS Lemon Zest Scented Sanitizer, Alcohol Antiseptic 70%, Non-sterile Topical Solution, 3.38 FL. OZ. (100 mL) a) Black and White Collection; b) Photo Real Collection", "product_quantity": "a) 4,680 bottles; b) 4,968 bottles", "reason_for_recall": "Chemical contamination: product found to be contaminated with methanol (wood alcohol), benzene and acetaldehyde.", "recall_initiation_date": "20210427", "center_classification_date": "20210719", "termination_date": "20221202", "report_date": "20210728", "code_info": "Lot #: 20255", "more_code_info": ""}, {"status": "Terminated", "city": "Parsippany", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87298", "recalling_firm": "Teva Pharmaceuticals USA", "address_1": "400 Interpace Pkwy", "address_2": "N/A", "postal_code": "07054-1120", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed nationwide in the USA and Puerto Rico.", "recall_number": "D-0281-2021", "product_description": "MethyIPREDNISolone Acetate Injectable Suspension USP, 80 mg/mL, 1 mL Single-Dose Vial (NDC 0703-0051-01), packaged in 25X1ML vials per tray (NDC 0703-0051-04), Rx only, Teva Pharmaceuticals USA, Inc., North Wales, PA  19454.", "product_quantity": "5,378 vials", "reason_for_recall": "Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.", "recall_initiation_date": "20210210", "center_classification_date": "20210221", "termination_date": "20240515", "report_date": "20210303", "code_info": "Lot # 31327909B, exp. date 04/2021  Lot # 31328352B, exp. date 07/2021"}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0846-2021", "product_description": "Neutrogena Beach Defense water+sun protection sunscreen spray BROAD SPECTRUM SPF 70, Avobenzone (3%), Homosalate (15%), Octisalate (5%), Octocrylene (10%), a) NET WT. 6.5 OZ. (184 g) (UPC 0 86800 87274 0) and b) NET WT. 8.5 OZ. (240 g) (UPC 0 86800 10048 5) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858", "product_quantity": "a) 3,672,204; b) 11,180 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "All lots within expiry"}, {"status": "Ongoing", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87941", "recalling_firm": "Global Sanitizers LLC", "address_1": "5979 S Valley View Blvd", "address_2": "N/A", "postal_code": "89118-3111", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product Distributed Nationwide in the USA", "recall_number": "D-0783-2021", "product_description": "MEDICALLY MINDED Hand Sanitizer Gel, ANTIMICROBIAL FORMULA, (Ethyl Alcohol 70% v/v), 8 Fl OZ (236 mL) bottle, Manufactured by Asiaticon, S.A. de C.V. Conkal 62, Jardines del Ajusco, Tlalpan, Ciudad de Mexico, C.P. 14200. Distributed by SBL Brands, LLC Las Vegas, NV 89119 UPC:  6 76753 00420 8 ,", "product_quantity": "N/A", "reason_for_recall": "CGMP Deviations:  lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.", "recall_initiation_date": "20210512", "center_classification_date": "20210830", "report_date": "20210908", "code_info": "Lot No: E332020, E212020 \"Best Buy\": 5/21/2022"}, {"status": "Terminated", "city": "Cranford", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA077060"], "brand_name": ["METFORMIN HYDROCHLORIDE"], "generic_name": ["METFORMIN HYDROCHLORIDE"], "manufacturer_name": ["Viona Pharmaceuticals Inc"], "product_ndc": ["72578-035", "72578-036"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["METFORMIN HYDROCHLORIDE"], "rxcui": ["860975", "860981"], "spl_id": ["ca52a4c2-f8fd-4395-a307-3c1ec9c3cf7f"], "spl_set_id": ["85027e6c-d35b-49eb-a234-dd71aa77aee0"], "package_ndc": ["72578-035-01", "72578-035-05", "72578-036-01", "72578-036-05"], "is_original_packager": [true], "unii": ["786Z46389E"]}, "product_type": "Drugs", "event_id": "88033", "recalling_firm": "VIONA PHARMACEUTICALS INC", "address_1": "20 Commerce Dr Ste 340", "address_2": "N/A", "postal_code": "07016-3617", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0640-2021", "product_description": "Metformin Hydrochloride Extended-Release Tablets, USP 750 mg, 100 Tablets, Rx only, Manufactured by: Cadila Healthcare Ltd. Ahmedabad, India. Distributed by: Viona Pharmaceuticals Inc. Cranford, NJ 07016  NDC 72578-036-01", "product_quantity": "21240 bottles", "reason_for_recall": "CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.", "recall_initiation_date": "20210601", "center_classification_date": "20210624", "termination_date": "20230531", "report_date": "20210630", "code_info": "Lot M915601 & M915602, Oct 2021"}, {"status": "Terminated", "city": "Livonia", "state": "MI", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA203437"], "brand_name": ["ENTACAPONE"], "generic_name": ["ENTACAPONE"], "manufacturer_name": ["Major Pharmaceuticals"], "product_ndc": ["0904-6822"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["ENTACAPONE"], "rxcui": ["317094"], "spl_id": ["3e89aac1-4b38-41fd-bbd7-af716570f424"], "spl_set_id": ["863025af-2b71-477d-baa9-3ce7f435e385"], "package_ndc": ["0904-6822-04", "0904-6822-07"], "original_packager_product_ndc": ["65862-654"], "nui": ["N0000175756", "N0000175757"], "pharm_class_moa": ["Catechol O-Methyltransferase Inhibitors [MoA]"], "pharm_class_epc": ["Catechol-O-Methyltransferase Inhibitor [EPC]"], "unii": ["4975G9NM6T"]}, "product_type": "Drugs", "event_id": "88638", "recalling_firm": "The Harvard Drug Group", "address_1": "17187 N Laurel Park Dr Ste 300", "address_2": "", "postal_code": "48152-2600", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "CO, FL, MO, OH", "recall_number": "D-0806-2021", "product_description": "Entacapone Tablets, USP, 200 mg, Rx only, 30 Tablets per unit dose cartons, Distributed by: Major Pharmaceuticals, 17177 N. Laurel Park Dr., Suite 233, Livonia, MI 48152.  NDC 0904-6822-04", "product_quantity": "1,632 cartons", "reason_for_recall": "Failed Dissolution Specifications", "recall_initiation_date": "20210729", "center_classification_date": "20210917", "termination_date": "20230219", "report_date": "20210929", "code_info": "Lot, expiry: N00187, 05/2022; N00245, 06/2022; N00273, 07/2022; N00355, 11/2022", "more_code_info": ""}, {"status": "Terminated", "city": "Tulsa", "state": "OK", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88275", "recalling_firm": "NATIVE PROMOTIONS, INC", "address_1": "1927 S Boston Ave Ste 205", "address_2": "N/A", "postal_code": "74119-5200", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Tribal nations in the following states: NC, MS, NY, FL, AL, SC, ME, CT, MA, VA, TX, LA, RI", "recall_number": "D-0793-2021", "product_description": "QiYu Hand Sanitizer (ethyl alcohol 75% (v/v)), 16.9 FL OZ (500 ML) bottles, Manufactured by: Guangzhou Minghui Cosmetics Co., Ltd, Baiyun District, Guanzhou, China Distributed by Native Promotional Products, Tulsa, OK NDC 74447-010", "product_quantity": "4,320 bottles", "reason_for_recall": "Subpotent", "recall_initiation_date": "20210712", "center_classification_date": "20210909", "termination_date": "20230929", "report_date": "20210915", "code_info": "Production Batch No.: Q20200510", "more_code_info": ""}, {"status": "Terminated", "city": "Columbus", "state": "OH", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA201578"], "brand_name": ["SIROLIMUS"], "generic_name": ["SIROLIMUS"], "manufacturer_name": ["American Health Packaging"], "product_ndc": ["68084-915"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SIROLIMUS"], "rxcui": ["349208"], "spl_id": ["3ccedad8-85eb-c609-e063-6294a90a7e2d"], "spl_set_id": ["5df60452-2b16-4ce9-8c29-48798a59d718"], "package_ndc": ["68084-915-95", "68084-915-25"], "original_packager_product_ndc": ["55111-653"], "nui": ["N0000175550", "N0000175625", "N0000175624", "N0000175605", "N0000175076"], "pharm_class_pe": ["Decreased Immunologic Activity [PE]"], "pharm_class_epc": ["mTOR Inhibitor Immunosuppressant [EPC]", "Kinase Inhibitor [EPC]"], "pharm_class_moa": ["mTOR Inhibitors [MoA]", "Protein Kinase Inhibitors [MoA]"], "unii": ["W36ZG6FT64"]}, "product_type": "Drugs", "event_id": "88650", "recalling_firm": "American Health Packaging", "address_1": "2550 John Glenn Ave Ste A", "address_2": "", "postal_code": "43217-1188", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the USA", "recall_number": "D-0813-2021", "product_description": "Sirolimus Tablets 1 mg, 30 Tablets (5 blister cards x 6 unit doses), Rx only, Packaged and Distributed by: American Health Packaging Columbus, OH 43217, NDC 68084-915-25", "product_quantity": "290 cartons", "reason_for_recall": "Failed Impurities/Degradation Specifications", "recall_initiation_date": "20210512", "center_classification_date": "20210920", "termination_date": "20220825", "report_date": "20210929", "code_info": "Lot #: 1000789, Exp. Date 10/31/2022", "more_code_info": ""}, {"status": "Terminated", "city": "South Beloit", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M013"], "brand_name": ["ACETAMINOPHEN"], "generic_name": ["ACETAMINOPHEN"], "manufacturer_name": ["Precision Dose, Inc."], "product_ndc": ["68094-030", "68094-231", "68094-330"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["ACETAMINOPHEN"], "rxcui": ["307668"], "spl_id": ["969e07e8-8e42-47bc-a77b-0ff7893d3175"], "spl_set_id": ["e1d4f562-433c-4344-9b77-1a7c731d1be5"], "package_ndc": ["68094-231-59", "68094-231-62", "68094-231-61", "68094-231-01", "68094-231-58", "68094-330-59", "68094-330-62", "68094-330-61", "68094-030-59", "68094-030-62"], "original_packager_product_ndc": ["0113-0212"], "unii": ["362O9ITL9D"]}, "product_type": "Drugs", "event_id": "88976", "recalling_firm": "Precision Dose Inc.", "address_1": "722 Progressive Ln", "address_2": "N/A", "postal_code": "61080-2616", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0095-2022", "product_description": "Acetaminophen Oral Suspension, 325 mg/10.15 mL,  packaged in 10.15 mL per cup (NDC Individual cup: 68094-330-59), in a) 30-count case (NDC 30-count case: 68094-330-62), and b) 100-count case (NDC 100-count case:  68094-330-61), Hospital Use Only, Pkg. Precision Dose, Inc., S. Beloit, IL 61080.", "product_quantity": "151,100 unit dose cups", "reason_for_recall": "cGMP Deviations: Product manufactured with contaminated raw ingredient.", "recall_initiation_date": "20211101", "center_classification_date": "20211105", "termination_date": "20240714", "report_date": "20211117", "code_info": "Lot#: 503679, 503693, 503715", "more_code_info": ""}, {"status": "Terminated", "city": "Fenton", "state": "MO", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88758", "recalling_firm": "SSM Health Care St. Louis DBA SSM St. Clare Health Center", "address_1": "1015 Bowles Ave", "address_2": "N/A", "postal_code": "63026-2394", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "E-Mail", "distribution_pattern": "MO", "recall_number": "D-0007-2022", "product_description": "Potassium Chloride 40 mEq in 0.9% Sodium Chloride 270 mL NS, 250 mL bag, Rx Only, SSM Health Care Corporation, 1015 Bowles, Fenton, MO.  NDC 60652-6429-1", "product_quantity": "385 bags", "reason_for_recall": "Lack of Assurance of Sterility", "recall_initiation_date": "20210922", "center_classification_date": "20211008", "termination_date": "20221228", "report_date": "20211020", "code_info": "Lot 210806-015, exp 11/4/2021"}, {"status": "Ongoing", "city": "Skillman", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88288", "recalling_firm": "Johnson & Johnson Consumer, Inc.", "address_1": "199 Grandview Rd", "address_2": "N/A", "postal_code": "08558-1311", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Nationwide in US", "recall_number": "D-0844-2021", "product_description": "Neutrogena Beach Defense water+sun protection sunscreen spray BROAD SPECTRUM SPF 50, Avobenzone (3%), Homosalate (10%), Octisalate (5%), Octocrylene (10%), NET WT. 6.5 OZ. (184 g) aerosol can, Distributed by: JOHNSON & JOHNSON CONSUMER, INC. Skillman, NJ 08858, UPC 0 86800 11254 9", "product_quantity": "1,437,804 cans", "reason_for_recall": "Chemical Contamination: presence of benzene", "recall_initiation_date": "20210714", "center_classification_date": "20210924", "report_date": "20211006", "code_info": "16621E01, exp 5/2024"}, {"status": "Terminated", "city": "Windsor", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "86990", "recalling_firm": "SCA Pharmaceuticals", "address_1": "755 Rainbow Rd Ste B", "address_2": "", "postal_code": "06095-1024", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product was distributed to hospitals nationwide.", "recall_number": "D-0196-2021", "product_description": "HYDROmorphone HCl 30 mg/30 mL in 0.9% Sodium Chloride Injection (1 mg/mL) a) 30 mL Plungerless Single Dose Syringe (barcode 70004030316) and b) 30 mL Single Dose Syringe (barcode 70004030321), Rx Only, SCA Pharmaceuticals, 755 Rainbow Rd., Windsor, CT, 06095", "product_quantity": "1,056 syringes", "reason_for_recall": "Lack of Assurance of Sterility; potential for a defective syringe cap, resulting in a non-integral unit", "recall_initiation_date": "20201217", "center_classification_date": "20210107", "termination_date": "20211102", "report_date": "20210113", "code_info": "a) Lot # 1220022964, BUD 1/19/2021; 1220023280, BUD 2/1/2021 &  1220023623, BUD 2/10/2021.  b) Lot # 1220023347, BUD 2/17/2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Madison", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["M018"], "brand_name": ["REFRESH RELIEVA PRESERVATIVE FREE"], "generic_name": ["CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN"], "manufacturer_name": ["Allergan, Inc."], "product_ndc": ["0023-6634"], "product_type": ["HUMAN OTC DRUG"], "route": ["OPHTHALMIC"], "substance_name": ["CARBOXYMETHYLCELLULOSE SODIUM", "GLYCERIN"], "rxcui": ["1100650"], "spl_id": ["c6440fb1-2b9b-4531-90e5-32fd270915b7"], "spl_set_id": ["3481f9b3-5a90-40d3-80f8-81f51cc864be"], "package_ndc": ["0023-6634-10", "0023-6634-01", "0023-6634-20"], "is_original_packager": [true], "nui": ["N0000185370", "N0000175629", "N0000184306", "N0000185001", "M0000728", "M0009417"], "pharm_class_epc": ["Non-Standardized Chemical Allergen [EPC]"], "pharm_class_pe": ["Increased Histamine Release [PE]", "Cell-mediated Immunity [PE]", "Increased IgG Production [PE]"], "pharm_class_cs": ["Allergens [CS]", "Glycerol [CS]"], "unii": ["K679OBS311", "PDC6A3C0OX"], "upc": ["300236634100"]}, "product_type": "Drugs", "event_id": "87016", "recalling_firm": "Allergan, PLC.", "address_1": "5 Giralda Farms", "address_2": "N/A", "postal_code": "07940-1027", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0233-2021", "product_description": "Refresh Relieva PF Preservative-Free Lubricant Eye Drops 0.33 fl oz (10 mL) Sterile Distributed by: Allergan, an AbbVie company Madison, NJ 07940 UPC 3 00236 63410 0, NDC 0023-6634-10.", "product_quantity": "100,634 bottles", "reason_for_recall": "Labeling: Missing instructions for use insert", "recall_initiation_date": "20201230", "center_classification_date": "20210119", "termination_date": "20230621", "report_date": "20210127", "code_info": "Lots: T0392 Exp. Jul. 2022, T0843 Exp. Aug. 2022", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0163-2022", "product_description": "TEST CYPIONATE 200MG/ANASTROZOLE 2MG/DUTASTERIDE 0.5MG/ML IN OIL  INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "4 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: T1006032021:45 BUD: 11/30/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Indianapolis", "state": "IN", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["BLA125469"], "brand_name": ["TRULICITY"], "generic_name": ["DULAGLUTIDE"], "manufacturer_name": ["Eli Lilly and Company"], "product_ndc": ["0002-3182", "0002-1433", "0002-1434", "0002-2236"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["DULAGLUTIDE"], "rxcui": ["1551295", "1551300", "1551304", "1551306", "2395777", "2395779", "2395783", "2395785"], "spl_id": ["2a046089-7cd3-43d3-9f7f-27e3e4b49f0d"], "spl_set_id": ["463050bd-2b1c-40f5-b3c3-0a04bb433309"], "package_ndc": ["0002-1433-01", "0002-1433-80", "0002-1433-61", "0002-1434-01", "0002-1434-80", "0002-1434-61", "0002-2236-01", "0002-2236-80", "0002-2236-61", "0002-3182-01", "0002-3182-80", "0002-3182-61"], "is_original_packager": [true], "nui": ["N0000178480", "M0160181", "N0000020058"], "pharm_class_epc": ["GLP-1 Receptor Agonist [EPC]"], "pharm_class_cs": ["Glucagon-Like Peptide 1 [CS]"], "pharm_class_moa": ["Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]"], "unii": ["WTT295HSY5"]}, "product_type": "Drugs", "event_id": "88505", "recalling_firm": "Eli Lilly & Company", "address_1": "839 S Delaware St", "address_2": "N/A", "postal_code": "46225-1782", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "USA Nationwide", "recall_number": "D-0773-2021", "product_description": "Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80", "product_quantity": "119,539 4-packs", "reason_for_recall": "Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product.", "recall_initiation_date": "20210819", "center_classification_date": "20210826", "termination_date": "20230807", "report_date": "20210901", "code_info": "Lot number: D396436C"}, {"status": "Terminated", "city": "Longview", "state": "TX", "country": "United States", "classification": "Class I", "openfda": {}, "product_type": "Drugs", "event_id": "88291", "recalling_firm": "Med Shop Total Care Inc.", "address_1": "470 E Loop 281", "address_2": "N/A", "postal_code": "75605-7939", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit", "distribution_pattern": "Texas and Puerto Rico", "recall_number": "D-0710-2021", "product_description": "MORPHINE-BUPIVACAINE PF INJECTABLE 21 mL, 22 mL, 23 mL, 41 mL and 43 mL syringes in various strengths: a) 20MG/ML-40MG/ML, b) 15MG-30MG/ML, c) 5MG/ML-20MG/ML, d) 2MG-30MG/ML, e) 20MG-5MG/ML, f) 15MG-5MG/ML, g) 5MG-2MG/ML, h) 5MG-11MG/ML, i) 20MG-6MG/ML, j) 10MG-10MG/ML, k) 6MG-4.8MG/ML, l) 30MG-10MG/ML, m) 5MG-4MG/ML, n) 10MG/ML-20MG/ML, o) 40MG-5MG/ML, p) 20MG-20MG/ML, q) 30MG-20MG/ML, Rx only, Med Shop Total Care 470 East Loop 281 Longview, TX 75605", "product_quantity": "466 mL", "reason_for_recall": "Non-Sterility", "recall_initiation_date": "20201005", "center_classification_date": "20210809", "termination_date": "20230817", "report_date": "20210818", "code_info": "Lot #: a) 09282020@62, BUD 10/27/2020, 09302020@25, BUD 10/29/2020, b) 09292020@56, c) 09292020@58, d)09292020@60, e) 09292020@66, 09292020@73, f) 09292020@70, g) 09292020@71, h) 09292020@77, i) 09302020@20 j) 09302020@33, k) 09302020@48, l) 09302020@61, m) 09302020@66, n) 09302020@70,  o) 09302020@26, BUD 10/29/2020, p) 10012020@8, q) 10022020@20,  BUD 10/30/2020"}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0889-2021", "product_description": "Strophanthus hisp 30X, Hives*, 20% Alcohol, Packaged in (a) 15 mL, UPC 7 40640 47553 9; (b) 30mL UPC 7 40640 47557 7; (c) 100mL, UPC 7 40640 47565 2; WHP Homeopathic Mecicine, 260 JR Hawvermale Way, Berkeley Springs, WV 25411", "product_quantity": "91 bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 29061"}, {"status": "Completed", "city": "Morton Grove", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88629", "recalling_firm": "Morton Grove Pharmaceuticals, Inc.", "address_1": "6451 Main St", "address_2": "", "postal_code": "60053-2633", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA and China", "recall_number": "D-0816-2021", "product_description": "Valproic Acid Oral Solution USP,  (250 mg/5 mL),  1 Pint (473 mL), Rx Only, Manufactured For: Wockhardt USA, LLC, Parsippany, NJ 07054; Manuractured By: Morton Grove Pharmaceuticals, Inc, Morton Grove, IL 60053. NDC: 60432-621-16", "product_quantity": "38,748 bottles", "reason_for_recall": "CGMP Deviations: Potential concern with products manufactured using liquid sugar batches contaminated with microbial organisms.", "recall_initiation_date": "20210903", "center_classification_date": "20210920", "report_date": "20210929", "code_info": "Lot #: UV1159", "more_code_info": ""}, {"status": "Terminated", "city": "Woodcliff Lake", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["505G(a)(3)"], "brand_name": ["PVP IODINE PREP PAD"], "generic_name": ["PROVIDONE IODINE"], "manufacturer_name": ["Professional Disposables International, Inc."], "product_ndc": ["10819-3883", "10819-3885"], "product_type": ["HUMAN OTC DRUG"], "route": ["TOPICAL"], "substance_name": ["POVIDONE-IODINE"], "rxcui": ["797730"], "spl_id": ["40ab78fb-f19d-ce27-e063-6294a90ae51d"], "spl_set_id": ["50c524ab-7029-494a-8bb4-d90a4d184fb2"], "package_ndc": ["10819-3883-1", "10819-3883-3", "10819-3885-1", "10819-3885-2", "0031081900"], "is_original_packager": [true], "nui": ["N0000175486", "M0011640"], "pharm_class_epc": ["Antiseptic [EPC]"], "pharm_class_cs": ["Iodine [CS]"], "unii": ["85H0HZU99M"]}, "product_type": "Drugs", "event_id": "88326", "recalling_firm": "Professional Disposables International, Inc", "address_1": "400 Chestnut Ridge Rd", "address_2": "N/A", "postal_code": "07677-7604", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the US", "recall_number": "D-0761-2021", "product_description": "PDI Povidone-Iodine Swabstick (3's), 3 Swabsticks, Professional Disposable International, Inc., Orangeburg, NY 10962 -1376  Reorder No S41125 NDC 10819-3885-2, UPC (01)00310819000185", "product_quantity": "51,926 cases", "reason_for_recall": "SubPotent: Out of Specification", "recall_initiation_date": "20210723", "center_classification_date": "20210820", "termination_date": "20230531", "report_date": "20210901", "code_info": "Lot #'s 11900761, EXP 2022-11-03; 11900917, EXP 2022-11-04; 11900918, EXP 2022-11-05; 11901008, EXP 2022-11-06; 11901009, EXP 2022-11-07; 11901124, EXP 2022-11-08; 11901125, EXP 2022-11-09; 11901126, EXP 2022-11-10;11901127, EXP 2022-11-11; 11901179, EXP 2022-11-12; 11901180, EXP 2022-11-13; 11901247, EXP 2022-11-14; 11901248, EXP 2022-11-15; 11901388, EXP 2022-11-16;11901389, EXP 2022-11-17; 11901390, EXP 2022-11-18; 11901419, EXP 2022-11-19; 11901420, EXP 2022-11-20; 11901480, EXP 2022-11-21; 11901558, EXP 2022-11-22;11901590, EXP 2022-11-23; 11901591, EXP 2022-11-24; 11901592, EXP 2022-11-25; 11901691, EXP 2022-11-26; 11901692, EXP 2022-11-27; 12000054, EXP 2022-11-28; 12000055, EXP 2022-11-29; 12000116, EXP 2022-11-30; 12000117, EXP 2022-12-01; 12000172, EXP 2022-12-02; 12000173, EXP 2022-12-03; 12000189, EXP 2022-12-04; 12000190, EXP 2022-12-05; 12000287, EXP 2022-12-06; 12000288, EXP 2022-12-07; 12000346, EXP 2022-12-08; 12000347, EXP 2022-12-09; 12000452, EXP 2022-12-10; 12000453, EXP 2022-12-11; 12000454, EXP 2022-12-12; 12000455, EXP 2022-12-13; 12000679, EXP 2022-12-14; 12000680, EXP 2022-12-15; 12000681, EXP 2022-12-16; 12000682, EXP 2022-12-17; 12000881, EXP 2022-12-18; 12000882, EXP 2022-12-19; 12000883, EXP 2022-12-20; 12000884, EXP 2022-12-21; 12001003, EXP 2022-12-22; 12001004, EXP 2022-12-23; 12001005, EXP 2022-12-24; 12001006, EXP 2022-12-25; 12001150, EXP 2022-12-26; 12001151, EXP 2022-12-27; 12001184, EXP 2022-12-28; 12001283, EXP 2022-12-29; 12001284, EXP 2022-12-30; 12001285, EXP 2022-12-31; 12001510, EXP 2023-01-01; 12001513, EXP 2023-01-02; 12001514, EXP 2023-01-03; 12001515, EXP 2023-01-04; 12001598, EXP 2023-01-05; 12001599, EXP 2023-01-06; 12001600, EXP 2023-01-07; 12001786, EXP 2023-01-08; 12001789, EXP 2023-01-09; 12001790, EXP 2023-01-10; 12001843, EXP 2023-01-11; 12001844, EXP 2023-01-12; 12001981, EXP 2023-01-13; 12001982, EXP 2023-01-14; 12002006, EXP 2023-01-15; 12002007, EXP 2023-01-16; 12002148, EXP 2023-01-17; 12002149, EXP 2023-01-18; 12100119, EXP 2023-01-19; 12100120, EXP 2023-01-20; 12100237, EXP 2023-01-21; 12100238, EXP 2023-01-22; 12100239, EXP 2023-01-23; 12100240, EXP 2023-01-24; 12100456, EXP 2023-01-25; 12100457, EXP 2023-01-26; 12100537, EXP 2023-01-27;"}, {"status": "Terminated", "city": "Wilton", "state": "CT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88770", "recalling_firm": "Beiersdorf Inc", "address_1": "45 Danbury Rd", "address_2": "N/A", "postal_code": "06897-4405", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0017-2022", "product_description": "Coppertone Pure & Simple baby 50 Sunscreen Spray (To Deliver) Zinc Oxide 24.08%, NET WT 5 OZ (142 g) can, Beiersdorf Inc., Wilton, CT 06897  UPC 0 72140 02881 7", "product_quantity": "14,748 cans", "reason_for_recall": "cGMP Deviations", "recall_initiation_date": "20210930", "center_classification_date": "20211015", "termination_date": "20230413", "report_date": "20211027", "code_info": "Lot# TN009GH, 03/31/2023"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0487-2021", "product_description": "Hydrocortisone Ointment USP 1% Maximum Strength Net Wt. 1 oz (28 g) NDC 0472-0345-56 Manufactured by: Actavis Mid Atlantic LLC 1877 Kawai Road, Lincolnton, NC 28902", "product_quantity": "23 tubes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "All Lots distributed 02/23/2021 through 03/10/2021"}, {"status": "Terminated", "city": "Fort Worth", "state": "TX", "country": "United States", "classification": "Class III", "openfda": {"brand_name": ["HYDROQUINONE"], "generic_name": ["HYDROQUINONE"], "manufacturer_name": ["Westminster Pharmaceuticals, LLC"], "product_ndc": ["69367-174"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["TOPICAL"], "substance_name": ["HYDROQUINONE"], "rxcui": ["197795"], "spl_id": ["c975cd31-f562-40a2-ae14-f31a00c5164e"], "spl_set_id": ["dc72c0b2-4505-4dcf-8a69-889cd9f41693"], "package_ndc": ["69367-174-01"], "is_original_packager": [true], "nui": ["N0000175851", "N0000175854", "N0000175850"], "pharm_class_pe": ["Depigmenting Activity [PE]"], "pharm_class_epc": ["Melanin Synthesis Inhibitor [EPC]"], "pharm_class_moa": ["Melanin Synthesis Inhibitors [MoA]"], "unii": ["XV74C1N1AE"], "upc": ["369367174015"]}, "product_type": "Drugs", "event_id": "88598", "recalling_firm": "Monarch PCM, LLC", "address_1": "7333 Jack Newell Blvd N Ste 100", "address_2": "", "postal_code": "76118-7151", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "OH, TN", "recall_number": "D-0818-2021", "product_description": "Hydroquinone, USP, 4% Skin Bleaching Cream, packaged in 1 oz (28.35g) tube, Rx only,  Manufactured for: Westminster Pharmaceuticals, LLC Nashville, TN 37217, NDC 69367-174-01 UPC 3 69367 17401 5", "product_quantity": "6305 tubes", "reason_for_recall": "Subpotency: one product for active ingredient assay and another one for preservative assay", "recall_initiation_date": "20210901", "center_classification_date": "20210920", "termination_date": "20230621", "report_date": "20210929", "code_info": "Lot: 21FP1731 Exp 05/2023", "more_code_info": ""}, {"status": "Terminated", "city": "Berkeley Springs", "state": "WV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88528", "recalling_firm": "Washington Homeopathic Products, Inc.", "address_1": "260 J R Hawvermale Way", "address_2": "N/A", "postal_code": "25411-6957", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Distributed Nationwide in the USA", "recall_number": "D-0883-2021", "product_description": "Z-1050 Formula Hepatodetox. Contents 1000ml. WHP Homeopathic Medicine, For Manufacturing Use Only, REMEDY: Cholesterinum 10X, Avena Sativa 12X, Cynara Scolymos 12X, Phosphorus 12X, Oroticum Acidum 13X, Aesculus Hipposcastanum 24X, Carduus Marianus 24X, Chelidonium Majus 24X, Cimicifuga Racemosa 24X, Cinchona Officinalis 24X, Colocynthis 24X, Histaminum Hydrochloricum 24X, Lycopodium Clavatum 24X, Sulphur 24X, Tataxacum Officinale 24X, Veratrum Album 24X, Sepia 30X, Strontium Carbonicum 30X, Dilution Alcohol 20%. Manufactured for Optimal Health Dimensions. RX Only. anufactured by Washington Homeopathic Products, Inc. 260 JR Hawvermale Way, Berkeley Springs, WV, 25411.", "product_quantity": "3/1 Liter bottles", "reason_for_recall": "Out-of-specification test results obtained for identification testing based on HPTLC analysis.", "recall_initiation_date": "20210820", "center_classification_date": "20210929", "termination_date": "20220621", "report_date": "20211006", "code_info": "Lot # 26071,  28180, Exp 8/17/2026"}, {"status": "Terminated", "city": "Princeton", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078878"], "brand_name": ["ACID REDUCER"], "generic_name": ["OMEPRAZOLE MAGNESIUM"], "manufacturer_name": ["LEADER/ Cardinal Health 110, Inc."], "product_ndc": ["70000-0232"], "product_type": ["HUMAN OTC DRUG"], "route": ["ORAL"], "substance_name": ["OMEPRAZOLE MAGNESIUM"], "rxcui": ["198051"], "spl_id": ["7dcc8f17-f79a-325e-bb4f-181efdfc0457"], "spl_set_id": ["1dc00f13-d1f5-15a0-32cc-4fc041865e72"], "package_ndc": ["70000-0232-1", "70000-0232-2", "70000-0232-3"], "original_packager_product_ndc": ["55111-397"], "unii": ["426QFE7XLK"]}, "product_type": "Drugs", "event_id": "88809", "recalling_firm": "Dr. Reddy's Laboratories, Inc.", "address_1": "107 College Rd E", "address_2": "N/A", "postal_code": "08540-6623", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0026-2022", "product_description": "Omeprazole Delayed-Release Capsules, 20 mg* (equivalent to 20.6 mg omeprazole magnesium),  24 Hour, 14-count capsules per bottle within a carton, Distributed by Cardinal Health, Dublin, OH 43017, NDC 70000-0232-1", "product_quantity": "8,976 bottles", "reason_for_recall": "CGMP Deviations: Customer complaint for the presence of a staple co-mingled with capsules within the bottle.", "recall_initiation_date": "20211005", "center_classification_date": "20211022", "termination_date": "20221206", "report_date": "20211027", "code_info": "BT001594C"}, {"status": "Terminated", "city": "Waltham", "state": "MA", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["NDA020171"], "brand_name": ["DELFLEX"], "generic_name": ["DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, SODIUM LACTATE, CALCIUM CHLORIDE, MAGNESIUM CHLORIDE"], "manufacturer_name": ["Fresenius Medical Care North America"], "product_ndc": ["49230-206", "49230-209", "49230-212"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAPERITONEAL"], "substance_name": ["CALCIUM CHLORIDE", "DEXTROSE MONOHYDRATE", "MAGNESIUM CHLORIDE", "SODIUM CHLORIDE", "SODIUM LACTATE"], "spl_id": ["38fafec0-59d7-1a67-e063-6294a90a8f1e"], "spl_set_id": ["bbc5b820-4973-11e2-a192-0002a5d5c51b"], "package_ndc": ["49230-206-20", "49230-206-30", "49230-206-32", "49230-206-50", "49230-206-60", "49230-206-62", "49230-206-52", "49230-209-23", "49230-209-30", "49230-209-32", "49230-209-50", "49230-209-60", "49230-209-62", "49230-209-52", "49230-212-23", "49230-212-30", "49230-212-32", "49230-212-50", "49230-212-60", "49230-212-62", "49230-212-52", "49230-0209-23"], "is_original_packager": [true], "unii": ["LX22YL083G", "451W47IQ8X", "M4I0D6VV5M", "02F3473H9O", "TU7HW0W0QT"]}, "product_type": "Drugs", "event_id": "87907", "recalling_firm": "Fresenius Medical Care Holdings, Inc.", "address_1": "920 Winter St Bld 950", "address_2": "N/A", "postal_code": "02451-1521", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide within the United States", "recall_number": "D-0605-2021", "product_description": "DELFLEX Peritoneal Dialysis Solution with 2.5 % Dextrose, Low Magnesium, Low Calcium, packaged in a) 3000 mL 2 packs (NDC 49230-0209-23), b) 3000 mL (NDC 49230-209-30) and c) 5000 mL (NDC 49230-209-50) Rx only, Fresenius Medical Care NA Waltham, MA 02451", "product_quantity": "672 cases", "reason_for_recall": "Temperature Abuse: Product exposed to temperature outside specified limits.", "recall_initiation_date": "20210428", "center_classification_date": "20210609", "termination_date": "20210917", "report_date": "20210616", "code_info": "Lot #: a) 20PU03043, Exp. Date June 2022; b) 20SU03036, Exp. date July 2022; c) 20Su07012, Exp. date July 2022; 21AU07021, 21AU02037, 21AU01007, 21AU01006, 21AU01019, Exp. date August 2022"}, {"status": "Terminated", "city": "Dublin", "state": "OH", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA209255"], "brand_name": ["CYANOCOBALAMIN"], "generic_name": ["CYANOCOBALAMIN"], "manufacturer_name": ["Vitruvias Therapeutics"], "product_ndc": ["69680-112", "69680-113", "69680-121"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["INTRAMUSCULAR"], "substance_name": ["CYANOCOBALAMIN"], "rxcui": ["309594"], "spl_id": ["7c3b0e85-bd17-4998-aaf4-1a873a357ab4"], "spl_set_id": ["2117af8a-723f-4e2f-98a6-83ad2c423751"], "package_ndc": ["69680-112-01", "69680-112-25", "69680-112-10", "69680-113-10", "69680-113-99", "69680-121-05", "69680-121-30", "69680-121-10"], "is_original_packager": [true], "nui": ["M0022794", "N0000175951"], "pharm_class_cs": ["Vitamin B 12 [CS]"], "pharm_class_epc": ["Vitamin B12 [EPC]"], "unii": ["P6YC3EG204"]}, "product_type": "Drugs", "event_id": "87512", "recalling_firm": "Cardinal Health Inc.", "address_1": "7000 Cardinal Pl", "address_2": "N/A", "postal_code": "43017-1091", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "FL, GA, SC", "recall_number": "D-0595-2021", "product_description": "CYANOCOBAL Injection 1000MCG/ML 25X1ML; NDC/UPC 69680-112-25; RX; MULTI DOSE VIAL", "product_quantity": "6 boxes", "reason_for_recall": "CGMP Deviations: Intermittent exposure to temperature excursion during storage.", "recall_initiation_date": "20210315", "center_classification_date": "20210524", "termination_date": "20240617", "report_date": "20210602", "code_info": "303824"}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0225-2022", "product_description": "TRI-MIX PAPAVERINE 40/PHENTOLAMINE 2/PGE-1 10 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "1 vial", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 04222021:98 BUD: 10/19/2021", "more_code_info": ""}, {"status": "Terminated", "city": "Bensalem", "state": "PA", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA202819"], "brand_name": ["SODIUM PHENYLBUTYRATE"], "generic_name": ["SODIUM PHENYLBUTYRATE"], "manufacturer_name": ["Sigmapharm Laboratories, LLC"], "product_ndc": ["42794-086"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["SODIUM PHENYLBUTYRATE"], "rxcui": ["984105"], "spl_id": ["d70f7f7c-f27a-db94-e053-2995a90a6937"], "spl_set_id": ["e914d451-6122-43f9-af8d-c80ed1cb215d"], "package_ndc": ["42794-086-14"], "is_original_packager": [true], "upc": ["0342794086144"], "unii": ["NT6K61736T"]}, "product_type": "Drugs", "event_id": "88736", "recalling_firm": "SigmaPharm Laboratories LLC", "address_1": "3375 Progress Dr", "address_2": "N/A", "postal_code": "19020-5801", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0898-2021", "product_description": "Sodium Phenylbutyrate Powder, 250 Grams, Rx Only, packaged in 500 cc HDPE bottles and 53 mm CRC caps packed in a carton and then in case packs containing 2 bottles. Sigmapharm Laboratories, LLC, Bensalem, PA 19020, NDC 42794-086-14", "product_quantity": "1192 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out of Specification impurity results obtained during routine testing.", "recall_initiation_date": "20210921", "center_classification_date": "20210930", "termination_date": "20220926", "report_date": "20211006", "code_info": "Lots 2005401,  2005501, 2005601, 2005701, Exp FEB 2023; Lots 2101401, 2101501, Exp  FEB-2024"}, {"status": "Terminated", "city": "Mesa", "state": "AZ", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88693", "recalling_firm": "First Royal Care Co. LLC, dba Red Mountain Compounding Pharmacy", "address_1": "6828 E Brown Rd Ste 101", "address_2": "N/A", "postal_code": "85207-3761", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "N/A", "distribution_pattern": "494 patients/consumers received prescriptions and are located in AZ, CA FL, MN, MT, TX, and UT.", "recall_number": "D-0039-2022", "product_description": "HYDROXYPROG CAPROATE 250MG/ML OIL INJ, Rx only, Red Mountain Compounding Rx", "product_quantity": "N/A", "reason_for_recall": "Lack of Assurance of Sterility: FDA inspection raised sterility assurance concerns", "recall_initiation_date": "20210813", "center_classification_date": "20211026", "termination_date": "20230412", "report_date": "20211103", "code_info": "all lots within expiry"}, {"status": "Terminated", "city": "Plainsboro", "state": "NJ", "country": "United States", "classification": "Class I", "openfda": {"application_number": ["BLA208751"], "brand_name": ["FIASP"], "generic_name": ["INSULIN ASPART INJECTION"], "manufacturer_name": ["Novo Nordisk"], "product_ndc": ["0169-3201", "0169-3204", "0169-3205", "0169-3206"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["SUBCUTANEOUS"], "substance_name": ["INSULIN ASPART"], "rxcui": ["311040", "1653196", "1653202", "1986354", "1986356", "2205454", "2642808", "2642809"], "spl_id": ["133d5f6e-b40f-47b6-ab47-10dc37114d79"], "spl_set_id": ["834e7efc-393f-4c55-9125-628562a8a5cf"], "package_ndc": ["0169-3201-11", "0169-3201-90", "0169-3204-15", "0169-3204-90", "0169-3204-97", "0169-3205-11", "0169-3205-15", "0169-3205-91", "0169-3205-95", "0169-3206-11", "0169-3206-15", "0169-3206-91", "0169-3206-95"], "is_original_packager": [true], "nui": ["M0011417", "N0000175453"], "pharm_class_cs": ["Insulin [CS]"], "pharm_class_epc": ["Insulin Analog [EPC]"], "unii": ["D933668QVX"]}, "product_type": "Drugs", "event_id": "87537", "recalling_firm": "Novo Nordisk Inc", "address_1": "800 Scudders Mill Rd", "address_2": "N/A", "postal_code": "08536-1606", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the USA", "recall_number": "D-0613-2021", "product_description": "Fiasp (insulin aspart injection), 100 units/mL (U-100), One 10 mL multi-dose vial, Sample. Not for Resale, Rx Only, Manufactured by: Novo Nordisk A/S, Bagsvaerd, Denmark, NDC 0169-3201-90", "product_quantity": "N/A", "reason_for_recall": "Temperature Abuse: product samples were stored at temperatures below 32* F which is not in accordance with storage requirements that could cause a lack of efficacy and damage to the cartridge and pen-injectors.", "recall_initiation_date": "20210322", "center_classification_date": "20210610", "termination_date": "20221209", "report_date": "20210421", "code_info": "KS6BX63 exp 10/31/2022;   KS6AK76 exp  05/31/2022;   KS6BR92 exp 09/30/2022"}, {"status": "Terminated", "city": "Baltimore", "state": "MD", "country": "United States", "classification": "Class III", "openfda": {"application_number": ["ANDA208347"], "brand_name": ["OSELTAMIVIR PHOSPHATE"], "generic_name": ["OSELTAMIVIR PHOSPHATE"], "manufacturer_name": ["Lupin Pharmaceuticals, Inc."], "product_ndc": ["68180-678"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["OSELTAMIVIR PHOSPHATE"], "rxcui": ["1115698"], "spl_id": ["7916db0e-271a-45a3-be4f-5ab7838a3127"], "spl_set_id": ["b428e1f2-0082-4d9f-908e-e3633ea0457b"], "package_ndc": ["68180-678-01"], "is_original_packager": [true], "unii": ["4A3O49NGEZ"]}, "product_type": "Drugs", "event_id": "87195", "recalling_firm": "Lupin Pharmaceuticals Inc.", "address_1": "Harborplace Tower", "address_2": "111 S Calvert St Fl 21st", "postal_code": "21202-6174", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide", "recall_number": "D-0247-2021", "product_description": "Oseltamivir Phosphate for Oral Suspension, 6 mg/mL, 60 mL (usable volume after constitution), Rx only, Manufactured for:Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad, Maharashtra, India. NDC: 68180-678-01", "product_quantity": "46,479 bottles", "reason_for_recall": "Failed Impurities/Degradation Specifications; Out-of-specification test results observed for Impurity C at 9 month long-term stability time point.", "recall_initiation_date": "20210121", "center_classification_date": "20210203", "termination_date": "20211216", "report_date": "20210210", "code_info": "Lot # A906423, exp. date Nov 2021.", "more_code_info": ""}, {"status": "Terminated", "city": "Colchester", "state": "VT", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87710", "recalling_firm": "Edge Pharma, LLC", "address_1": "856 Hercules Dr", "address_2": "N/A", "postal_code": "05446-8014", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide in the US", "recall_number": "D-0335-2021", "product_description": "Betadine (Povidone-Iodine) 5%, 0.5mL per syringe Single Use Syringe Rx only, For Topical Ophthalmic Use (DO NOT INJECT) STERILE OPHTHALMIC SOLUTION, PRESERVATIVE FREE, Edge Pharma, LLC 856 Hercules Dr. Colchester, VT 05446 Customer Service (USA) 1-802-992-1178", "product_quantity": "5850 syringes", "reason_for_recall": "Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility", "recall_initiation_date": "20210412", "center_classification_date": "20210419", "termination_date": "20220211", "report_date": "20210428", "code_info": "Lot 02-2021-16@4 BUD 5/31/2021", "more_code_info": ""}, {"status": "Ongoing", "city": "New York", "state": "NY", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88497", "recalling_firm": "Pfizer Inc.", "address_1": "235 East 42nd Street", "address_2": "", "postal_code": "10017-5703", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Press Release", "distribution_pattern": "Nationwide", "recall_number": "D-0811-2021", "product_description": "Chantix (varenicline) tablets 1 mg, Carton containing 4 blister packs of 14 tablets each,, Rx only,  Distributed by Pfizer Labs, Division of Pfizer Inc. NY, NY 10017, Made in Ireland, NDC 0069-0469-03.  EXPIRATION DATE: September 2021   June 2023", "product_quantity": "", "reason_for_recall": "CGMP Deviations: Presence of the N-nitroso-varenicline impurity above FDA s acceptable interim acceptable intake limit", "recall_initiation_date": "20210813", "center_classification_date": "20210917", "report_date": "20210929", "code_info": "Lots 00019431, 00019542, 00019543, 00019544, 00020814, 00020815, 00020907, 00020965, 00021421, 00021422, 00021423, 00022136, 00022174, 00022175, 00022176, 00022177, 00022765, 00022766, 00023134, 00023135, 00023747, 00023748, DL3896, DL7779, DR2614, DX4576, DX5870, DX5871, DX5872, DX5873, DX7805, DY6078, DY7060, DY9367, DY9473, DY9475, DY9476, DY9505, EC5910, EC5913, EE9391, EF2346, EM4805, EM4807, EN2005, ET1601, ET1605, ET1606  EXPIRATION DATE: September 2021   December 2023", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0186-2022", "product_description": "TRI-MIX PAPAVERINE 15/PHENTOLAMINE 0.25/PGE-1 6 INJ   INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "24 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot:08192021:49 BUD: 02/08/2022; 08102021:33 BUD: 11/30/2021; 06302021:75 BUD: 10/23/2021; 09032021:05 BUD: 02/08/2022", "more_code_info": ""}, {"status": "Ongoing", "city": "Las Vegas", "state": "NV", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87941", "recalling_firm": "Global Sanitizers LLC", "address_1": "5979 S Valley View Blvd", "address_2": "N/A", "postal_code": "89118-3111", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Product Distributed Nationwide in the USA", "recall_number": "D-0778-2021", "product_description": "MEDICALLY MINDED ANTIMICROBIAL Hand Sanitizer Gel with Aloe Vera, (Ethyl Alcohol 70% v/v), 10 FL OZ / 300 mL, Manufactured by Grupo V-Klean S.A. de C.V, Calle Alborada 124, Parques del Pedregal, Tlalpan, 14250 Ciudad de Mexico, CDMX, Distributed by SBL Brands, LLC. Las Vegas, NV 89119. Made in Mexico UPC: 6 76753 00417 8", "product_quantity": "50,000 bottles", "reason_for_recall": "CGMP Deviations: lots and products of hand sanitizer are being recalled because they were manufactured under the same conditions as the product lot found to contain methanol.", "recall_initiation_date": "20210512", "center_classification_date": "20210830", "report_date": "20210908", "code_info": "Lot No: GV4420205 Best By, 5/21/2022"}, {"status": "Terminated", "city": "Lake Forest", "state": "IL", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "87462", "recalling_firm": "Akorn, Inc.", "address_1": "1925 W Field Ct Ste 300", "address_2": "N/A", "postal_code": "60045-4862", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide USA", "recall_number": "D-0301-2021", "product_description": "Gabapentin Oral Solution, 250 mg/5 mL, 5 mL per unit dose cup, four unit dose cups per tray, For Institutional Use Only, Rx only, Hi-Tech Pharmacal Co., Inc, Amityville, NY 11701, NDC Tray: 50383-311-07; NDC Unit Dose Cup 50383-311-07", "product_quantity": "8,183 unit dose cups", "reason_for_recall": "Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing", "recall_initiation_date": "20210308", "center_classification_date": "20210316", "termination_date": "20220809", "report_date": "20210324", "code_info": "Lot 369409, Exp. Date 05/2021; Lot 372393, Exp. Date 01/2022;  Lot 373112, Exp. Date 04/2022"}, {"status": "Terminated", "city": "Mahwah", "state": "NJ", "country": "United States", "classification": "Class II", "openfda": {"application_number": ["ANDA078314"], "brand_name": ["NAPROXEN SODIUM"], "generic_name": ["NAPROXEN SODIUM"], "manufacturer_name": ["Glenmark Pharmaceuticals Inc., USA"], "product_ndc": ["68462-178", "68462-188", "68462-189", "68462-190", "68462-179"], "product_type": ["HUMAN PRESCRIPTION DRUG"], "route": ["ORAL"], "substance_name": ["NAPROXEN SODIUM"], "rxcui": ["198012", "198013", "198014", "849398", "849431"], "spl_id": ["b7cce793-fe49-4fe0-8848-fc89f7ea3832"], "spl_set_id": ["6c5bb008-e66f-4ef0-bf84-aca7eb5983e9"], "package_ndc": ["68462-188-01", "68462-188-05", "68462-189-01", "68462-189-05", "68462-190-30", "68462-190-50", "68462-190-01", "68462-190-05", "68462-178-01", "68462-178-05", "68462-179-01", "68462-179-05"], "is_original_packager": [true], "upc": ["0368462190012", "0368462179017", "0368462178010", "0368462189016", "0368462188019"], "nui": ["N0000000160", "M0001335", "N0000175722"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]"], "unii": ["9TN87S3A3C", "57Y76R9ATQ"]}, "product_type": "Drugs", "event_id": "88591", "recalling_firm": "Glenmark Pharmaceuticals Inc., USA", "address_1": "750 Corporate Dr", "address_2": "", "postal_code": "07430-2009", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Letter", "distribution_pattern": "Nationwide.", "recall_number": "D-0821-2021", "product_description": "Naproxen Sodium Tablets, USP 275 mg 100 Tablets Rx Only NDC 68462-178-01 Manufactured by: Glenmark Pharmaceuticals Inc., USA 4147 Goldmine Road Monroe, NC 28110 Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430", "product_quantity": "9552 bottles", "reason_for_recall": "CGMP Deviations", "recall_initiation_date": "20210827", "center_classification_date": "20210921", "termination_date": "20231004", "report_date": "20210929", "code_info": "Lots: 29190087 Exp. 10/31/2021; 29190088 Exp. 10/31/2021; 29190089 Exp. 10/31/2021; 29200077 Exp. 11/30/2022; 29200078 Exo, 11/30/2022", "more_code_info": ""}, {"status": "Terminated", "city": "San Antonio", "state": "TX", "country": "United States", "classification": "Class II", "openfda": {}, "product_type": "Drugs", "event_id": "88862", "recalling_firm": "Vita Pharmacy, LLC dba Talon Compounding Pharmacy", "address_1": "2950 Thousand Oaks Dr Ste 25", "address_2": "N/A", "postal_code": "78247-3347", "voluntary_mandated": "Voluntary: Firm initiated", "initial_firm_notification": "Telephone", "distribution_pattern": "United States including Washington, D.C. and Puerto Rico", "recall_number": "D-0149-2022", "product_description": "VITAMIN D3 100,000 IU/ML INJECTABLE 100,000IU/ML, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247", "product_quantity": "23 vials", "reason_for_recall": "Lack of assurance of sterility", "recall_initiation_date": "20211012", "center_classification_date": "20211108", "termination_date": "20231004", "report_date": "20211117", "code_info": "Lot: 05272021:20 BUD: 11/23/2021; 06142021:34 BUD: 12/11/2021; 08052021:18 BUD: 01/05/2022; 08192021:43 BUD: 01/05/2022; 03302021:15 BUD: 08/12/2021", "more_code_info": ""}]